KR20200081542A - Composition for cosmetic comprising compounds extracted from eisenia bicyclis - Google Patents

Composition for cosmetic comprising compounds extracted from eisenia bicyclis Download PDF

Info

Publication number
KR20200081542A
KR20200081542A KR1020180170136A KR20180170136A KR20200081542A KR 20200081542 A KR20200081542 A KR 20200081542A KR 1020180170136 A KR1020180170136 A KR 1020180170136A KR 20180170136 A KR20180170136 A KR 20180170136A KR 20200081542 A KR20200081542 A KR 20200081542A
Authority
KR
South Korea
Prior art keywords
rhubarb
extract
cosmetic composition
rhubarb extract
ethanol
Prior art date
Application number
KR1020180170136A
Other languages
Korean (ko)
Inventor
김명욱
김은주
임수빈
김종석
Original Assignee
재단법인 환동해산업연구원
영덕군
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 재단법인 환동해산업연구원, 영덕군 filed Critical 재단법인 환동해산업연구원
Priority to KR1020180170136A priority Critical patent/KR20200081542A/en
Publication of KR20200081542A publication Critical patent/KR20200081542A/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a cosmetic composition comprising an Eisenia bicyclis extract as an active ingredient. Particularly, the present invention relates to a cosmetic composition comprising, as an active ingredient, an Eisenia bicyclis extract which is effective in antioxidation, anti-inflammation, and skin wrinkle reduction by extracting and using useful ingredients from Eisenia bicyclis using ethanol or water.

Description

대황(Eisenia bicyclis) 추출물을 유효성분으로 하는 화장료 조성물{COMPOSITION FOR COSMETIC COMPRISING COMPOUNDS EXTRACTED FROM EISENIA BICYCLIS}Cosmetic composition using Eisenia bicyclis extract as an active ingredient {COMPOSITION FOR COSMETIC COMPRISING COMPOUNDS EXTRACTED FROM EISENIA BICYCLIS}

본 발명은 대황 추출물을 유효성분으로 하는 화장료 조성물에 관한 것으로서, 구체적으로는 대황을 에탄올이나 물을 이용하여 유용성분을 추출하고 이를 이용하여 항산화, 항염증 및 피부 주름 개선에 효과가 있는 대황 추출물을 유효성분으로 하는 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition using an rhubarb extract as an active ingredient, specifically extracting useful components using rhubarb using ethanol or water and using it to extract antioxidants, antioxidants, and skin wrinkles that are effective in improving wrinkles. It relates to a cosmetic composition as an active ingredient.

생활과 소득 수준이 높아지고 향상되면서 사람들은 의식주에 따른 일상적인 라이프스타일에서 벗어나 개인의 미적 생활에도 관심이 증대되고 있다(기능성 화장품과 기능성 식품의 구매 형태 및 선호도에 관한 연구. 편이숙. 서경대학교 대학원. 석사학위논문. 2010.). 특히, 현대의학의 발전으로 인하여 평균수명이 늘어나고 여유로워짐에 따라 노화방지, 피부건강 등에도 많은 관심을 가지고 있다(Kim, S.H. Yong, H.J. Shin, C. and Ko, S.G. Research of traditional herbal medicines for anti-aging, inhibition effect of wrinkle and whitening effect in the skin. Korean J . Ori. Physiol. Pathol. 2008, 22, 691-698.).As living and income levels have risen and improved, people have become increasingly interested in personal aesthetic life, away from everyday lifestyles due to consciousness (a study on the purchase form and preference of functional cosmetics and functional foods. Master's Thesis. 2010.). In particular, with the development of modern medicine, as the average lifespan increases and becomes more relaxed, there is much interest in anti-aging and skin health (Kim, SH Yong, HJ Shin, C. and Ko, SG Research of traditional herbal medicines for anti-aging, inhibition effect of wrinkle and whitening effect in the skin.Korean J. Ori.Physiol.Pathol. 2008, 22, 691-698.).

피부의 노화는 그 요인에 따라 내인적 노화와 외인적 노화로 구분할 수 있다. 내인적 노화는 피부의 구조와 생리적 기능이 나이를 먹으면서 쇠퇴하는 것이며, 외인적 노화는 태양광선 등 누적된 외부 스트레스에 의해 노화 현상이 나타나는 것이다. 특히 각종 오염물질과 자외선 노출 등 외인적 노화에 의해 피부가 얇아지며, 주름이 증가되고 탄력이 감소될 뿐만 아니라, 기미, 주근깨 및 검버섯이 증가하게 된다(Gilchrest BA. Skin aging and photoaging. Dermatol Nurs. 1990, 2, 79-82., Kang, K.S. Kim, I.D. Kwon, R.H. Heo, Y.Y. Oh, S.H. Kim, M.A. Jung, H.J. Kang, H.Y. Ha, B.J. The evaluation of anti-wrinkle effects in oriental herb extract. J . Life Sci , 2007, 17, 1147-1151.). 피부 노화가 진행될수록 피부를 구성하는 물질인 콜라겐, 엘라스틴, 히알루론산 등 구조 단백질을 생성하는 능력이 감소하고 type-1 collagenase의 생합성이 증가하여 matrix metalloproteinases(MMPs)의 발현이 증가되면 진피 내 교원 섬유, 탄력 섬유, fibronectin과 같은 기질 단백질 분해를 유도하여 피부탄력을 떨어뜨리고 피부 주름생성을 야기한다(Brenneisen P, Sies H, Scharffetter-Kochannek K. “Ultraviolet-B irradiation and matrix metalloproteinases: from induction via signaling to initial events” Ann. N. Y. Acad. Sci , 2002, 973, 31-43.).The aging of the skin can be divided into intrinsic and exogenous aging depending on the factors. Intrinsic aging is the deterioration of the skin's structure and physiological functions as it ages, and extrinsic aging is an aging phenomenon caused by accumulated external stress such as sunlight. In particular, skin is thinned by exogenous aging such as exposure to various pollutants and UV rays, wrinkles are increased, elasticity is reduced, and spots, freckles, and blotch are increased (Gilchrest BA. Skin aging and photoaging. Dermatol Nurs. 1990, 2, 79-82., Kang, KS Kim, ID Kwon, RH Heo, YY Oh, SH Kim, MA Jung, HJ Kang, HY Ha, BJ The evaluation of anti-wrinkle effects in oriental herb extract.J. Life Sci, 2007, 17, 1147-1151.). As skin aging progresses, the ability to produce structural proteins such as collagen, elastin, and hyaluronic acid, which are the constituents of the skin, decreases, and biosynthesis of type-1 collagenase increases, resulting in increased expression of matrix metalloproteinases (MMPs). , Induce decomposition of matrix proteins such as elastic fibers and fibronectin, thereby reducing skin elasticity and causing skin wrinkles (Brenneisen P, Sies H, Scharffetter-Kochannek K. “Ultraviolet-B irradiation and matrix metalloproteinases: from induction via signaling to initial events” Ann. NY Acad. Sci, 2002, 973, 31-43.).

이러한 피부 노화 및 주름 생성 방지 등 피부 건강뿐만 아니라 신체 전반적인 건강 유지 및 향상을 위해 다양한 천연물을 이용한 화장품, 식품 및 의약품 등의 연구가 활발하게 이루어지고 있다.In order to maintain and improve not only skin health, such as preventing skin aging and wrinkle formation, but also maintaining and improving overall health of the body, research on cosmetics, food, and medicines using various natural products has been actively conducted.

우리나라에는 3면이 바다로 이루어져 있어 해역에 서식하는 해조류의 종류가 매우 다양하고 풍부하다. 이들 해조류는 오래 전부터 식용, 호료, 약용, 해조공업의 원료, 비료 등으로 널리 이용되어 왔다. 최근에는 해조류에 식물 못지않게 다양한 기능성 성분을 함유하고 있어 이러한 기능성 성분의 분리와 그 효능의 검증 및 활용에 대해 활발히 연구되어지고 있다(Choi, D.M., Kim, D.S., Lee, D.S., Kim, H.R., and Pyeun, J.H. 1995. Trace components and functional sacchsrides in seaweed-1. J. Korean Fish. Soc. 28 : 49-59.).In Korea, three sides are composed of the sea, so the types of seaweeds inhabiting the sea area are very diverse and rich. These seaweeds have been widely used as food, fertilizer, medicinal, raw materials and fertilizer for the seaweed industry for a long time. Recently, as seaweeds contain as many functional ingredients as plants, it has been actively researched for the separation and verification and utilization of these functional ingredients (Choi, DM, Kim, DS, Lee, DS, Kim, HR, and Pyeun, JH 1995. Trace components and functional sacchsrides in seaweed-1. J. Korean Fish. Soc. 28: 49-59.).

대형 갈조류 대황(Eisenia bicyclis)은 갈조강 다시마목 감태과 대황속에 속하는 다년생 해조류로, 우리나라 울릉도, 독도에 대군락을 형성하고 있으며 동해안에서는 경북 영덕에 군락이 발달해 있다(대황 배우체와 아포체의 생장에 미치는 온도, 광량, 광주기의 영향. 이민정. 경상대학교 대학원. 석사학위논문. 2018.). 대황에는 요오드와 칼륨이 다량 함유되어 있고, 독특한 맛으로 인해 옛날부터 다시마 대용으로 식용이 되어 지고 있으며, 최근에는 알긴산의 원료로 이용되고 있다(대황 추출물의 생리활성과 응용. 김대용. 부경대학교 대학원. 석사학위논문.2009.). The large brown algae (Eisenia bicyclis) is a perennial seaweed belonging to the kelp tree kelp tree and rhododendron. It forms a large colony on Korea's Ulleungdo and Dokdo Islands, and colonies are developing in Yeongdeok, Gyeongbuk, on the east coast. Effects of temperature, light intensity, and Gwangju period. Lee Min-jung. Graduate school of Gyeongsang National University. Master's thesis. 2018.). Rhubarb contains a large amount of iodine and potassium, and has been edible as a kelp substitute since ancient times due to its unique taste, and has recently been used as a raw material for alginic acid (physiological activity and application of rhubarb extract. Daeyong Kim. Graduate School of Pukyong National University. Master's Thesis. 2009.).

대황의 기능성에 대한 연구도 활발하게 이루어지고 있는데, 특히 항균(Eom SH, Lee BJ and Kim YM. 2010. Effect of yeast fermentation on the antioxidant and anti-inflammatory activity of sea tangle water extract. Korean J Fish Aquat Sci 43, 117-124.), 항염증(Jung, HA, Jin SE, Ahn BR, Lee CM and Choi JS. 2013. Anti-inflammatory activity of edible brown alga Eisenia bicyclis and its constituents fucosterol and phlorotannins in LPS-stimulated RAW264.7 macrophages. Food Chem Toxicol 59, 199-206.), 항고지혈증(Jang YH, Choi SW and Cho SH. 2008. Effect of Eisenia bicyclis and its pill on serum lipid status in rats fed high fat diet. Korean J Food Nutri 41, 5-12.), 항당뇨(Okada Y, Ishimaru A, Suzuki R and Okuyama T. 2004. A new phloroglucinol derivative from the brown alga Eisenia bicyclis: potential for the effective treatment of diabetic complications. J Nat Prod 67, 103-105.) 등의 다양한 효능을 가지고 있다고 보고되어 있다. 또한, 대황은 플로로탄닌과 같은 생리활성 물질을 다량 함유하고 있고, 대황에서 분리된 플로로탄닌은 eckol과 phlorofucofuroeckol-A, dieckol, 8,8’-bieckol 등이 있으며 항산화 활성을 지닌다고 보고되고 있다(Okada Y, Ishimaru A, Suzuki R and Okuyama T. 2004. A new phloroglucinol derivative from the brown alga Eisenia bicyclis: potential for the effective treatment of diabetic complications. J Nat Prod 67, 103-105.).Research on the functionality of rhubarb has also been actively conducted, especially antibacterial (Eom SH, Lee BJ and Kim YM. 2010. Effect of yeast fermentation on the antioxidant and anti-inflammatory activity of sea tangle water extract.Korean J Fish Aquat Sci 43, 117-124.), anti-inflammatory (Jung, HA, Jin SE, Ahn BR, Lee CM and Choi JS. 2013.Anti-inflammatory activity of edible brown alga Eisenia bicyclis and its constituents fucosterol and phlorotannins in LPS-stimulated RAW264 .7 macrophages.Food Chem Toxicol 59, 199-206.), Antihyperlipidemia (Jang YH, Choi SW and Cho SH. 2008.Effect of Eisenia bicyclis and its pill on serum lipid status in rats fed high fat diet.Korean J Food Nutri 41, 5-12.), anti-diabetes (Okada Y, Ishimaru A, Suzuki R and Okuyama T. 2004.A new phloroglucinol derivative from the brown alga Eisenia bicyclis: potential for the effective treatment of diabetic complications.J Nat Prod 67 , 103-105.). In addition, rhubarb contains a large amount of physiologically active substances such as chlorotannin, and chlorotannin isolated from rhubarb has eckol and phlorofucofuroeckol-A, dieckol, 8,8'-bieckol, and has been reported to have antioxidant activity. (Okada Y, Ishimaru A, Suzuki R and Okuyama T. 2004.A new phloroglucinol derivative from the brown alga Eisenia bicyclis: potential for the effective treatment of diabetic complications.J Nat Prod 67, 103-105.).

한편, 한국공개특허 제10-2013-0141874호에는 대황 유래 플로로탄닌 화합물을 유효성분으로 하는 항균성 조성물에 관한 것으로서, 상기 항균제 조성물은 특히 MRSA(Methicillin-Resistant Staphylococcus aureus)에 대해 매우 우수한 항균활성을 갖는 플로로탄닌 화합물을 유효성분으로 포함하는 항균 조성물에 대해 개시하고 있다.On the other hand, Korean Patent Publication No. 10-2013-0141874 relates to an antimicrobial composition comprising an rhubarb-derived polotanin compound as an active ingredient, and the antimicrobial composition has particularly excellent antibacterial activity against MRSA (Methicillin-Resistant Staphylococcus aureus). Disclosed is an antimicrobial composition comprising a fluorotannin compound as an active ingredient.

한국등록특허 제10-0966128호는 해조류 대황으로부터 대황분말 제조, 압출성형 및 효소가수분해에 의하여 제조되는 고지혈증 및 당뇨 치료 효과를 갖는 대황 효소추출물, 상기 대황 효소추출물에 대황분말, 다시마분말 및 부형제를 혼합하여 제조되는 대황정제환 및 이의 제조방법에 대해 개시하고 있다.Korean Registered Patent No. 10-0966128 discloses rhubarb enzyme extract, rhubarb powder, kelp powder, and excipients for rhubarb enzyme extract, which has the effect of treating hyperlipidemia and diabetes, produced by rhubarb powder production, extrusion molding and enzymatic hydrolysis from seaweed rhubarb. Disclosed is a rhubarb tablet manufactured by mixing and a method for manufacturing the same.

한국공개특허 제10-2011-0057586호는 갈조류 대황 분말, 대황 효소추출물, 다시마 분말 및 부형제로 이루어진 당뇨병 예방 또는 치료용 약제학적 조성물 및 당뇨병 개선용 건강기능식품 조성물에 대해 개시하고 있다.Korean Patent Publication No. 10-2011-0057586 discloses a pharmaceutical composition for preventing or treating diabetes and a health functional food composition for improving diabetes, consisting of brown algae rhubarb powder, rhubarb enzyme extract, kelp powder and excipients.

상기와 같이 대황에 대한 다양한 연구가 진행되고 있으며 그 기능성이 알려지고 있으나, 아직까지 그 활용도가 미흡하며, 특히 피부 개선에 대한 기능성 검증 및 화장료 등에 대한 산업적 응용은 매우 저조한 실정이다.As described above, various studies on rhubarb have been conducted, and its functionality is known, but its utilization is still insufficient, and in particular, industrial applications for functional verification and cosmetics for skin improvement are very poor.

한국공개특허 제10-2013-0141874호(2013.12.27.)Korean Patent Publication No. 10-2013-0141874 (2013.12.27.) 한국등록특허 제10-0966128호(2010.06.17.)Korean Registered Patent No. 10-0966128 (2010.06.17.) 한국공개특허 제10-2011-0057586호(2011.06.01.)Korean Open Patent No. 10-2011-0057586 (2011.06.01.)

본 발명은 상술한 것과 같은 문제점을 해결하고 필요한 기술을 제공하기 위해 안출된 것으로서,The present invention has been devised to solve the problems as described above and to provide the necessary technology,

본 발명은 항산화, 항염증 및 피부 주름 개선에 효과가 있는 화장료 조성물을 제공하기 위하여 해조류 대황을 이용하여 이를 추출 및 농축한 것을 이용한 화장료 조성물을 제공함에 그 목적이 있다.An object of the present invention is to provide a cosmetic composition using extracts and concentrates using seaweed rhubarb to provide a cosmetic composition that is effective in improving antioxidant, anti-inflammatory and skin wrinkles.

상기와 같은 목적을 달성하기 위한 본 발명의 일 실시 형태로서,As one embodiment of the present invention for achieving the above object,

본 발명은 대황 추출물을 유효성분으로 하는 화장료 조성물을 제공한다.The present invention provides a cosmetic composition using rhubarb extract as an active ingredient.

이때, 상기 대황 추출물은 건조하여 분쇄한 대황 100중량부에 대해 800 내지 1200중량부의 에탄올을 첨가한 후, 실온에서 20 내지 25시간 동안 추출하여 대황 추출액을 제조하는 추출단계; 상기 추출단계에서 제조된 대황 추출액에 함유된 고형분을 분리 제거하고, 고형분이 제거된 추출액을 40 내지 50℃의 온도에서 감압농축하여 10 내지 20Brix의 대황 농축액을 제조하는 농축단계; 및 상기 농축단계에서 제조된 대황 농축액을 -70 내지 -80℃의 온도에서 동결시킨 후 이를 동결건조하여 대황추출물을 제조하는 동결건조단계;를 포함하여 제조되는 것을 특징으로 할 수 있다.At this time, the rhubarb extract is extracted by adding 800 to 1200 parts by weight of ethanol to 100 parts by weight of dried and crushed rhubarb, and then extracting for 20 to 25 hours at room temperature to prepare a rhubarb extract; Concentration step of separating and removing the solid content contained in the rhubarb extract prepared in the extraction step, and concentrated under reduced pressure at a temperature of 40 to 50 ℃ the solid content is removed to prepare a rhubarb concentrate of 10 to 20 Brix; And a freeze-drying step of preparing the rhubarb extract by freezing the rhubarb concentrate prepared in the concentration step at a temperature of -70 to -80°C and then freeze-drying it.

또한, 상기 대황 추출물은 건조하여 분쇄한 대황 100중량부에 대해 800 내지 1200중량부의 물을 가한 후, 90 내지 100℃에서 2 내지 3시간 동안 추출하여 대황 추출액을 제조하는 추출단계; 상기 추출단계에서 제조된 대황 추출액에 함유된 고형분을 분리 제거하고, 고형분이 제거된 추출액을 60 내지 70℃의 온도에서 감압농축하여 10 내지 20Brix의 대황 농축액을 제조하는 농축단계; 및 상기 농축단계에서 제조된 대황 농축액을 -70 내지 -80℃의 온도에서 동결시킨 후 이를 동결건조하여 대황추출물을 제조하는 동결건조단계;를 포함하여 제조되는 것을 특징으로 할 수 있다.In addition, the rhubarb extract is extracted by adding 800 to 1200 parts by weight of water to 100 parts by weight of dried and crushed rhubarb, followed by extraction at 90 to 100°C for 2 to 3 hours to prepare a rhubarb extract; Concentration step of separating and removing the solid content contained in the rhubarb extract prepared in the extraction step, and concentrated under reduced pressure at a temperature of 60 to 70 ℃ the solid content is removed to prepare a 10 to 20 Brix rhubarb concentrate; And a freeze-drying step of preparing the rhubarb extract by freezing the rhubarb concentrate prepared in the concentration step at a temperature of -70 to -80°C and then freeze-drying it.

본 발명에 있어서 상기 화장료 조성물은 화장수, 로션, 세럼, 마사지크림, 영양크림, 모이스처크림, 핸드크림, 에센스, 영양에센스, 바디로션으로 구성된 군으로부터 선택된 어느 하나의 제형으로 제조되는 것을 특징으로 할 수 있다.In the present invention, the cosmetic composition may be characterized in that it is made of any one selected from the group consisting of lotion, lotion, serum, massage cream, nutrition cream, moisture cream, hand cream, essence, nutrition essence, body lotion have.

본 발명의 일 실시형태에 따른 대황 추출물을 유효성분으로 함유하는 화장료 조성물은 대황을 에탄올이나 물을 이용하여 유용성분을 추출하고 이를 이용하여 화장료 조성물을 제조함으로써 항산화, 항염증 및 피부 주름 개선의 장점이 있음에 따라 다양한 제형의 화장료 조성물로 사용될 수 있다.Cosmetic composition containing rhubarb extract as an active ingredient according to an embodiment of the present invention extracts useful components using rhubarb using ethanol or water and prepares a cosmetic composition using them to improve antioxidant, anti-inflammatory and skin wrinkles According to this, it can be used as a cosmetic composition of various formulations.

도 1은 대황 추출물에 대한 DPPH radical 소거능을 측정한 결과를 나타내는 그래프이다.
도 2는 대황 추출물에 대한 ABTS radical 소거능을 측정한 결과를 나타내는 그래프이다.
도 3은 대황 추출물에 대한 SOD 유사활성 측정 결과를 나타내는 그래프이다.
도 4는 대황 추출물에 대한 Superoxide dismutase (SOD) 효소활성 측정 결과를 나타내는 그래프이다.
도 5는 대황 추출물에 대한 세포생존률 확인 결과를 나타내는 그래프이다.
도 6은 RAW 264.7 cell에 대한 대황 추출물의 세포 독성 측정 결과를 나타내는 그래프이다.
도 7은 대황 추출물에 대한 Nitric oxide 저해율 측정 결과를 나타내는 그래프이다.
도 8은 Western blot을 통한 대황 추출물의 iNOS 생성저해 측정 결과를 나타내는 그래프이다.
도 9는 Western blot을 통한 대황 추출물의 COX-2 생성저해 측정 결과를 나타내는 그래프이다.
도 10은 Real-time PCR 분석을 통한 대황 추출물의 iNOS 및 COX-2 발현 억제 효능 결과를 나타내는 그래프이다.
도 11은 HaCaT cell에 대한 대황 추출물의 세포 독성 측정 결과를 나타내는 그래프이다.
도 12는 Western blot을 통한 대황 추출물의 MMP-1 단백질 발현 측정 결과를 나타내는 그래프이다.
1 is a graph showing the results of measuring the DPPH radical scavenging activity for rhubarb extract.
2 is a graph showing the results of measuring the ABTS radical scavenging activity for rhubarb extract.
3 is a graph showing the results of measuring SOD-like activity for rhubarb extract.
4 is a graph showing the results of measuring superoxide dismutase (SOD) enzyme activity for rhubarb extract.
5 is a graph showing the cell viability check results for rhubarb extract.
6 is a graph showing the cytotoxicity measurement results of rhubarb extract for RAW 264.7 cell.
7 is a graph showing the measurement results of Nitric oxide inhibition rate for rhubarb extract.
8 is a graph showing the measurement results of iNOS production inhibition of rhubarb extract through Western blot.
9 is a graph showing the measurement results of COX-2 production inhibition of rhubarb extract through Western blot.
10 is a graph showing the results of iNOS and COX-2 expression inhibition efficacy of rhubarb extract through real-time PCR analysis.
11 is a graph showing the cytotoxicity measurement results of rhubarb extract for HaCaT cells.
12 is a graph showing the measurement results of MMP-1 protein expression of rhubarb extract through Western blot.

이하, 본원의 발명이 속하는 기술분야에서 통상의 지식을 가진 자가 용이하게 실시할 수 있도록 본 발명의 실시형태를 들어 상세히 설명한다. 본 발명의 실시형태는 당업계에서 평균적인 지식을 가진 자에게 본 발명을 더욱 완전하게 설명하기 위해서 제공되는 것이다. 따라서, 본 발명의 실시형태는 여러 가지 다른 형태로 변형될 수 있으며, 본 발명의 범위가 이하 설명하는 실시형태로 한정되는 것은 아니다.Hereinafter, embodiments of the present invention will be described in detail so that those skilled in the art to which the present invention pertains may easily practice. Embodiments of the present invention are provided to more fully describe the present invention to those skilled in the art. Accordingly, the embodiments of the present invention can be modified in various other forms, and the scope of the present invention is not limited to the embodiments described below.

본 발명의 명세서 전체에서, 어떤 부분이 어떤 구성요소를 “포함”한다고 할 때, 이는 특별히 반대되는 기재가 없는 한 다른 구성요소를 제외하는 것이 아니라 다른 구성 요소를 더 포함할 수 있는 것을 의미한다.Throughout the specification of the present invention, when a part “includes” a certain component, it means that the component may further include other components, not to exclude other components, unless specifically stated to the contrary.

본 발명의 명세서 전체에서 사용되는 정도의 용어 “약”, “실질적으로” 등은 언급된 의미에 고유한 제조 및 물질 허용 오차가 제시될 때 그 수치에서 또는 그 수치에 근접한 의미로 사용되고, 본 발명의 이해를 돕기 위해 정확하거나 절대적인 수치가 언급된 개시 내용을 비양심적인 침해자가 부당하게 이용하는 것을 방지하기 위해 사용된다. The terms “about”, “substantially”, and the like used throughout the specification of the present invention are used in terms of or close to those values when manufacturing and material tolerances unique to the stated meanings are presented, and the present invention To help understand, accurate or absolute figures are used to prevent unconscionable abusers from unintentionally using the disclosed disclosure.

본 발명은 대황 추출물을 유효성분으로 함유하는 화장료 조성물(이하, ‘화장료 조성물’이라고도 함)을 제공한다.The present invention provides a cosmetic composition (hereinafter also referred to as'cosmetic composition') containing rhubarb extract as an active ingredient.

본 발명에 따른 화장료 조성물은 대황에 에탄올이나 물을 가하여 추출한 대황 추출액을 농축 및 동결건조하여 제조한 대황 추출물을 유효성분으로 함유하는 것으로, 항산화, 항염증, 주름 개선 효과가 높을 것으로 기대된다.The cosmetic composition according to the present invention contains the rhubarb extract prepared by concentrating and lyophilizing the rhubarb extract extracted by adding ethanol or water to rhubarb as an active ingredient, and is expected to have high antioxidant, anti-inflammatory, and wrinkle-improving effects.

본 발명의 일 실시형태에 따르면, 상기 화장료 조성물에 포함되는 대황 추출물은 건조하여 분쇄한 대황 100중량부에 대해 800 내지 1200중량부의 에탄올을 첨가한 후 실온에서 20 내지 25시간 동안 추출하여 대황 추출액을 제조하는 추출단계, 상기 추출단계에서 제조된 대황 추출액에 함유된 고형분을 분리 제거하고, 고형분이 제거된 추출액을 40 내지 50℃의 온도에서 감압농축하여 10 내지 20Brix의 대황 농축액을 제조하는 농축단계 및 상기 농축단계에서 제조된 대황 농축액을 -70 내지 -80℃의 온도에서 동결시킨 후 이를 동결건조하여 대황추출물을 제조하는 동결건조단계를 포함하여 제조한 것임을 특징으로 할 수 있다.According to one embodiment of the present invention, the rhubarb extract contained in the cosmetic composition is added to 800 to 1200 parts by weight of ethanol to 100 parts by weight of dried and crushed rhubarb, and then extracted at room temperature for 20 to 25 hours to extract the rhubarb extract Extraction step to prepare, the concentration step of separating and removing the solid content contained in the rhubarb extract prepared in the extraction step, and concentrated under reduced pressure at a temperature of 40 to 50 ℃ the solid content is removed to prepare a 10 to 20 Brix rhubarb concentrate and It can be characterized in that the rhubarb concentrate prepared in the concentration step is freeze-dried at a temperature of -70 to -80°C and then freeze-dried to prepare a rhubarb extract.

또한, 본 발명의 일 실시형태에 따르면, 상기 화장료 조성물에 포함되는 대황 추출물은 건조하여 분쇄한 대황 100중량부에 대해 800 내지 1200중량부의 물을 가한 후, 90 내지 100℃에서 2 내지 3시간 동안 추출하여 대황 추출액을 제조하는 추출단계, 상기 추출단계에서 제조된 대황 추출액에 함유된 고형분을 분리 제거하고, 고형분이 제거된 추출액을 60 내지 70℃의 온도에서 감압농축하여 10 내지 20Brix의 대황 농축액을 제조하는 농축단계 및 상기 농축단계에서 제조된 대황 농축액을 -70 내지 -80℃의 온도에서 동결시킨 후 이를 동결건조하여 대황추출물을 제조하는 동결건조단계를 포함하여 제조한 것임을 특징으로 할 수 있다.In addition, according to one embodiment of the present invention, the rhubarb extract contained in the cosmetic composition is added to 800 to 1200 parts by weight of water with respect to 100 parts by weight of dried and crushed rhubarb, and then at 90 to 100° C. for 2 to 3 hours Extraction step to extract the rhubarb extract, the solid content contained in the rhubarb extract prepared in the extraction step is separated and removed, and concentrated extract is removed at a temperature of 60 to 70 ℃ concentrated under reduced pressure to 10 to 20 Brix rhubarb concentrate It can be characterized in that it comprises a concentration step to prepare and freeze-drying step to prepare the rhubarb concentrate prepared in the concentration step by freezing at a temperature of -70 to -80 ℃ and then freeze-drying it.

대황 추출물 제조 시 상기와 같이 한정한 범위를 벗어날 경우, 추출물 내에 유용성분의 함량이 낮거나 묽은 농도로 인해 항산화, 항염증 및 피부 주름 개선 효과를 기대할 수 없으며, 반대로 추출물의 농도가 너무 높아 항산화, 항염증 및 피부 주름 개선 효과가 향상 효과를 가질 수 있을지라도 화장료 제조에 있어 제조단가가 높아지고 오히려 피부 독성 또한 발생할 수 있다는 우려가 있다.When the rhubarb extract is out of the limited range as described above, anti-oxidation, anti-inflammatory and skin wrinkle improvement effects cannot be expected due to low or dilute concentration of useful ingredients in the extract. Conversely, the concentration of the extract is too high for antioxidant, Although the anti-inflammatory and anti-wrinkle effect may have an improvement effect, there is a concern that the manufacturing cost is high in the manufacture of cosmetic products, and skin toxicity may also occur.

이때, 대황 추출물을 화장료 조성물로 이용할 때 상기 화장료 조성물은 대황 추출물이 화장료 조성물 전체 중량%에 대해 0.1 내지 90중량%의 비율로 포함되는 것을 특징으로 할 수 있다.At this time, when using the rhubarb extract as a cosmetic composition, the cosmetic composition may be characterized in that the rhubarb extract is included in a proportion of 0.1 to 90% by weight relative to the total weight of the cosmetic composition.

이는 화장료 조성물 전체 중량%에 대해 대황 추출물이 0.1중량% 미만의 비율로 포함되는 경우에는 항산화, 항염증 및 피부 주름 개선 효과가 제대로 발현되지 않을 수 있으며, 화장료 조성물 전체 중량%에 대해 대황 추출물이 90중량%를 초과하는 비율로 포함되는 경우에는 화장료 제조에 있어 제조단가가 높아진다는 문제점이 발생할 수 있다.This is that when the rhubarb extract is contained in a proportion of less than 0.1% by weight relative to the total weight% of the cosmetic composition, antioxidant, anti-inflammatory and skin wrinkle improvement effects may not be properly expressed, and rhubarb extract is 90% based on the total weight% of the cosmetic composition When included in a proportion exceeding weight%, there may be a problem that the manufacturing cost increases in the manufacture of cosmetic products.

또한, 본 발명에 따른 화장료 조성물은 통상의 방법에 화장수, 로션, 세럼, 마사지크림, 영양크림, 모이스처크림, 핸드크림, 에센스, 영양에센스, 바디로션으로 구성된 군으로부터 선택된 어느 하나의 제형으로 제형화하여 사용될 수 있다.In addition, the cosmetic composition according to the present invention is formulated into any one formulation selected from the group consisting of lotion, lotion, serum, massage cream, nourishing cream, moisture cream, hand cream, essence, nutrient essence, and body lotion in a conventional method Can be used.

이하, 본 발명을 구체적인 실시예에 따라 상세히 설명한다. 본 발명의 일 실시형태에 따라 제조된 화장료 조성물은 대황 추출물 수율 및 수득량 측정 실험, 영양소 분석 실험, 무기질 및 중금속 측정 실험, 구성 아미노산 측정 실험, 유리 아미노산 측정 실험, 지방산 조성 실험, 항산화 효과 실험, 항염증 효과 실험, 주름 개선 효과 실험을 실시하였다. 본 발명의 일 실시형태에 따른 화장료 조성물은 후술하는 실험에 의하여 보다 명확하게 이해될 수 있다.Hereinafter, the present invention will be described in detail according to specific embodiments. The cosmetic composition prepared according to one embodiment of the present invention is a rhubarb extract yield and yield measurement experiment, nutrient analysis experiment, mineral and heavy metal measurement experiment, constituent amino acid measurement experiment, free amino acid measurement experiment, fatty acid composition experiment, antioxidant effect experiment, Anti-inflammatory effect experiment and wrinkle improvement effect experiment were conducted. The cosmetic composition according to an embodiment of the present invention can be more clearly understood by experiments described below.

대황 추출물의 제조(1) : 에탄올 추출물 제조Preparation of rhubarb extract (1): Preparation of ethanol extract

1. 추출단계 : 건조하여 분쇄한 대황 100중량부에 대해 1000중량부의 에탄올을 첨가한 후 실온에서 24시간 동안 추출하여 대황 추출액을 제조한다. 1. Extraction step: 1000 parts by weight of ethanol was added to 100 parts by weight of dried and crushed rhubarb, and then extracted at room temperature for 24 hours to prepare a rhubarb extract.

2. 농축단계 : 상기 대황 추출액에 함유된 고형분을 필터(Advantec Filter paper No.2)를 이용하여 분리 제거하고, 고형분이 제거된 추출액을 45℃의 온도에서 감압농축하여 15Brix의 대황 농축액을 제조한다. 2. Concentration step: The solid content contained in the rhubarb extract is separated and removed using a filter (Advantec Filter paper No.2), and the extract from which the solid is removed is concentrated under reduced pressure at a temperature of 45° C. to prepare 15Brix rhubarb concentrate. .

3. 동결건조단계 : 상기 대황 농축액을 -70℃의 온도에서 동결시킨 후 동결건조하여 대황 추출물을 제조한다. 3. Freeze-drying step: The rhubarb concentrate is frozen at a temperature of -70°C and then lyophilized to prepare a rhubarb extract.

대황 추출물의 제조(2) : 물(열수) 추출물 제조Preparation of rhubarb extract (2): Preparation of water (hot water) extract

1. 추출단계 : 건조하여 분쇄한 대황 100중량부에 대해 1000중량부의 물을 첨가한 후 100℃에서 2시간 30분 동안 추출하여 대황 추출액을 제조한다. 1. Extraction step: After adding 1000 parts by weight of water to 100 parts by weight of dried and crushed rhubarb, extract at 100°C for 2 hours and 30 minutes to prepare a rhubarb extract.

2. 농축단계 : 상기 대황 추출액에 함유된 고형분을 필터(Advantec Filter paper No.2)를 이용하여 분리 제거하고, 고형분이 제거된 추출액을 65℃의 온도에서 감압농축하여 15Brix의 대황 농축액을 제조한다. 2. Concentration step: The solid content contained in the rhubarb extract is separated and removed using a filter (Advantec Filter paper No.2), and the extract from which the solid is removed is concentrated under reduced pressure at a temperature of 65° C. to prepare 15Brix rhubarb concentrate. .

3. 동결건조단계 : 상기 대황 농축액을 -70℃의 온도에서 동결시킨 후 동결건조하여 대황 추출물을 제조한다. 3. Freeze-drying step: The rhubarb concentrate is frozen at a temperature of -70°C and then lyophilized to prepare a rhubarb extract.

대황 추출물 수율 및 수득량 측정 실험Experiment for measuring the yield and yield of rhubarb extract

에탄올을 이용하여 제조한 대황 추출물(이하 “에탄올추출물”이라고 함)과 물을 이용하여 제조한 대황 추출물(이하 “열수추출물”이라고 함)에 대해 수율 및 수득량을 측정하였다. 에탄올추출물의 경우 10, 20, 30, 40, 50, 60, 70, 80, 90 및 100%로 에탄올 농도를 달리하여 추출물을 제조한 후 그에 대한 수율 및 수득량을 측정하였다.Yield and yield were measured for rhubarb extract (hereinafter referred to as “ethanol extract”) prepared using ethanol and rhubarb extract (hereinafter referred to as “hot water extract”) prepared using water. In the case of ethanol extract, extracts were prepared by varying the ethanol concentration to 10, 20, 30, 40, 50, 60, 70, 80, 90 and 100%, and then the yield and yield were measured.

실험결과Experiment result

에탄올 농도별 대황추출물의 경우 50~70% 에탄올을 이용한 추출물에서 추출 수율이 가장 높게 나타났다. 에탄올추출물과 열수추출물에 대한 수율 및 수득량에 대한 측정 결과는 표 1과 같다.In the case of rhubarb extract by ethanol concentration, the extraction yield was highest in extracts using 50-70% ethanol. Table 1 shows the measurement results of the yield and yield for the ethanol extract and the hot water extract.

대황 추출Rhubarb extract 수율 (%)Yield (%) 수득량 (g)Yield (g) 열수Hydrothermal 36.3236.32 145.28 g (400g 추출)145.28 g (400 g extracted) 10% EtOH10% EtOH 11.3711.37 22.73 g (200g 추출)22.73 g (200 g extraction) 20% EtOH20% EtOH 17.8317.83 35.66 g (200g 추출)35.66 g (200 g extraction) 30% EtOH30% EtOH 21.3821.38 42.76 g (200g 추출)42.76 g (200 g extraction) 40% EtOH40% EtOH 24.8824.88 49.76 g (200g 추출)49.76 g (200 g extraction) 50% EtOH50% EtOH 27.9027.90 55.79 g (200g 추출)55.79 g (200 g extraction) 60% EtOH60% EtOH 29.6929.69 59.37 g (200g 추출)59.37 g (200 g extraction) 70% EtOH70% EtOH 25.9825.98 51.95 g (200g 추출)51.95 g (200 g extraction) 80% EtOH80% EtOH 19.3319.33 38.66 g (200g 추출)38.66 g (200 g extraction) 90% EtOH90% EtOH 8.368.36 16.71 g (200g 추출)16.71 g (200 g extraction) 100% EtOH100% EtOH 1.591.59 3.17 g (200g 추출)3.17 g (200 g extraction) *EtOH : 에탄올추출물*EtOH: Ethanol extract

영양소 측정 실험Nutrient measurement experiment

1. 조단백질 정량1. Determination of crude protein

조단백질 정량은 AOAC에 준하여 Kjeldahl법으로 측정하였다. 채취된 시료를 Kjeldahl 분해관에 취해 Kjeldahl(Foss, Sweden) 장치를 이용하여 0.1N NaOH용액으로 적정하고, 질소계수(6.25)를 곱하여 조단백질의 함량을 산출하였다. The crude protein was quantified using the Kjeldahl method according to AOAC. The collected sample was taken into a Kjeldahl decomposition tube, titrated with a 0.1N NaOH solution using a Kjeldahl (Foss, Sweden) device, and multiplied by a nitrogen coefficient (6.25) to calculate the content of crude protein.

2. 조지방 정량 실험2. Crude fat quantitative experiment

조지방은 Soxhlet법으로 측정하였다. 즉 시료 5g 내외를 원통여과지에 넣고, 시료 위를 탈지면으로 막고서 추출관 속에 넣어 수기 속에 에테르를 채운 후 60℃ 수욕상에서 8~16 시간 동안 추출하고서 수기 속의 에테르를 날려 보내고 지방의 무게를 측정하였다.Crude fat was measured by the Soxhlet method. That is, about 5 g of the sample was placed in a cylindrical filter paper, the sample was blocked with cotton wool, placed in an extraction tube, filled with ether in water, extracted for 8 to 16 hours in a water bath at 60°C, the ether in the water was blown, and the weight of fat was measured. .

3. 조회분 정량3. Quantification of inquiry

회분은 AOAC에 준하여 직접 회화법으로 항량을 알고 있는 도가니에 일정량의 시료를 취하여 550~600℃의 회화로에서 5~6시간 회화하고 데시케이터에서 일정 시간 방냉하여 항량을 구하여 회화 전후의 항량차로서 조회분량을 산출하였다.Ash content is obtained by taking a certain amount of sample in a crucible that knows the constant weight by direct painting method according to AOAC, painting it for 5 to 6 hours in a 550-600°C furnace, and cooling it for a period of time in a desiccator to obtain the constant weight to obtain the constant weight. The amount of inquiry was calculated as.

4. 탄수화물 정량4. Carbohydrate determination

시료 전체를 100%로 하1여 수분, 조단백질, 조지방, 회분, 함량 %를 감한 것을 탄수화물(carbohydrates) 함량(%)으로 하였다.Carbohydrates content (%) was determined by subtracting water, crude protein, crude fat, ash, and content% from 100% of the total sample.

5. 유리당 정량5. Quantification of free sugar

당류의 함량은 시료 약 5 g을 50 mL 메스플라스크에 정밀히 달아 물 25 mL를 가하여 녹인 후 아세토니트릴로 50 mL까지 채우고 이를 0.45 μL의 멤브레인 필터로 여과한 것을 시험용액으로 하였다.The content of the saccharide was about 5 g of the sample, precisely weighed into a 50 mL volumetric flask, dissolved in 25 mL of water, filled to 50 mL with acetonitrile, and filtered through a 0.45 μL membrane filter as a test solution.

Fructose, Glucose, Sucrose, Maltose, Lactose의 표준품(Sigma, USA)을 각각 100 mL용 메스플라스크에 0.1 g을 정밀히 달아 물 50 mL로 녹인 후 아세토니트릴로 100 mL까지 채운 후, 희석하여 표준용액으로 사용하였다. 시료 중 당류 함량은 HPLC를 이용하여 표 2와 같은 조건으로 분석하였다.Fructose, Glucose, Sucrose, Maltose, and Lactose (Sigma, USA) are precisely weighed with 100 g of a 100 mL measuring flask, dissolved in 50 mL of water, filled with acetonitrile to 100 mL, diluted, and used as a standard solution. Did. The sugar content in the sample was analyzed under the conditions shown in Table 2 using HPLC.

ItemsItems ConditionsConditions Instrument Instrument Waters, USA (Empower system)Waters, USA (Empower system) ColumnColumn 250㎜×4.6㎜, Polyamine Ⅱ(YMC Pack)250㎜×4.6㎜, Polyamine II (YMC Pack) DetectorDetector RIRI Mobile phaseMobile phase Water : Acetonitrile (20:70, v/v)Water: Acetonitrile (20:70, v/v) Injection volumeInjection volume 20㎕20 μl Flow rateFlow rate 1.0㎖/min1.0ml/min Column tempColumn temp 35℃35℃

6. 콜레스테롤 측정6. Cholesterol measurement

비누화 과정 : 검체(대황 추출물) 약 2g을 정밀히 칭량하여 삼각플라스크에 취하였다. 이때 검체의 지방량은 1 g이하가 되도록 검체량을 조절 하였다. 자석막대를 삼각플라스크에 넣고 95% 에탄올 40 mL과 8 mL 50% 수산화칼륨용액을 가하였다. 콘덴서를 설치하고 자석교반-가열기를 이용하여 교반하면서 가열하여 70±10분간 환류 시켰다. 비누화를 위해 시료를 지속적으로 관찰하면서 덩어리가 생길 경우 유리봉으로 분산시키거나 교반하면서 50% 수산화칼륨용액을 추가하여 시험용액을 교반하였다. 환류가 완료되면 가열기를 끄고 교반 중에 콘덴서의 상부를 통해 95% 에탄올 60 mL을 첨가 하였다. 약 15분 후, 콘덴서를 플라스크에서 제거하고 플라스크에 마개를 막아 실온으로 냉각시킨 후, 24시간 동안 시험용액을 안정화 하였다.Saponification process: About 2 g of the sample (rhubarb extract) was precisely weighed and taken into an Erlenmeyer flask. At this time, the amount of fat in the sample was adjusted to be 1 g or less. The magnetic rod was placed in an Erlenmeyer flask, and 40 mL of 95% ethanol and 50 mL of 8 mL 50% potassium hydroxide solution were added. A condenser was installed and heated with stirring using a magnetic stirring-heater to reflux for 70±10 minutes. For saponification, if a lump occurs while continuously observing the sample, the test solution is stirred by adding 50% potassium hydroxide solution while dispersing or stirring with a glass rod. When reflux was completed, the heater was turned off and 60 mL of 95% ethanol was added through the top of the condenser during stirring. After about 15 minutes, the condenser was removed from the flask, the flask was capped, cooled to room temperature, and the test solution was stabilized for 24 hours.

추출 : 비누화가 끝난 시험용액을 교반하면서 톨루엔 100 mL을 첨가하고 마개를 하여 30초 이상 교반하였다. 이를 세척과정 없이 500 mL 분액여두로 옮긴 후 110 mL 1M 수산화칼륨용액을 분액여두에 넣고 10초간 강렬하게 진탕하여 정치하고 분리된 아래층을 버렸다. 40 mL 0.5 M 수산화칼륨용액을 분액여두에 넣고 분액여두를 뒤집은 후 천천히 내용물이 소용돌이가 생기도록 10초간 섞어준 후 정치하여 분리된 아래층을 버렸다. 톨루엔 층을 40 mL 증류수로 천천히 분액여두를 돌려주며 수세하고 정치하여 분리된 아래층을 버리고 수세과정을 3회 이상 반복하였다. 이 때 수세과정이 반복될수록 더욱 강렬하게 진탕하였다. 톨루엔 층이 맑게 보일 때까지 수세과정을 계속하였다. 유리솜과 약 20 g의 무수황산나트륨이 채워진 유리깔때기를 통해 수세한 톨루엔을 약 2 g 무수황산나트륨이 채워진 삼각플라스크로 흘려주어 탈수하였다. 삼각플라스크에 마개를 막고 교반하여 혼합한 후 15분 이상 정치하였다. 추출한 톨루엔 층 25 mL을 바닥이 평평한 125 mL 둥근 플라스크에 취하고 이를 40±3℃에서 감압 농축하여 증발건조시키고 잔류물에 아세톤 약 3 mL을 가한 후 다시 감압 농축하여 완전 건고하였다.Extraction: 100 ml of toluene was added while stirring the test solution after saponification was completed, and the mixture was stirred for 30 seconds or more. After transferring it to a 500 mL separatory wort without washing, 110 mL 1M potassium hydroxide solution was added to the separatory strainer and shaken vigorously for 10 seconds to agitate and the separated lower layer was discarded. 40 mL 0.5 M potassium hydroxide solution was added to the separatory filter and the separatory filter was turned over. Then, the contents were slowly mixed for 10 seconds to form a vortex. The toluene layer was washed with 40 mL of distilled water slowly, washed with water, and left to stand. The separated lower layer was discarded and the washing process was repeated three or more times. At this time, the more the washing process was repeated, the more intense the agitation. The washing process was continued until the toluene layer was clear. The toluene washed with glass wool and a glass funnel filled with about 20 g of anhydrous sodium sulfate was dehydrated by flowing into an Erlenmeyer flask filled with about 2 g of anhydrous sodium sulfate. The cap was placed in an Erlenmeyer flask, stirred and mixed to stand for at least 15 minutes. 25 mL of the extracted toluene layer was taken into a 125 mL round flask with a flat bottom, concentrated under reduced pressure at 40±3°C, evaporated to dryness, and about 3 mL of acetone was added to the residue, followed by concentration under reduced pressure to complete dryness.

유도체화 : 표준용액 및 상기의 시험용액 1.0 mL을 15 mL 원심분리관에 각각 취하고 각 원심분리관에 0.2 mL 헥사메틸디실란를 가한 후, 0.1 mL 트리메틸클로로실란를 가하여 마개를 닫고 이를 강렬하게 30초간 교반 혼합하고 15분간 정치하였다. 각각의 원심분리관에 1.0 mL 5α-콜레스탄(Cholestane) 내부표준용액과 증류수 10 mL을 넣은 후 마개를 닫고 30초간 강렬하게 교반하고 이를 3000 rpm에서 2분간 원심분리 하였다. 상층의 헵탄 층을 취하여 기체크로마토그래프(Shimadzu GC-2010) 측정용 시험용액으로 하였다. 콜레스테롤 정량을 분석하기 위한 분석 조건은 하기 표 3과 같다.Derivatization: 1.0 mL of the standard solution and the test solution described above were respectively taken into a 15 mL centrifuge tube, 0.2 mL hexamethyldisilane was added to each centrifuge tube, 0.1 mL trimethylchlorosilane was added, the cap was closed, and this was stirred vigorously for 30 seconds. Mix and stand for 15 minutes. After adding 1.0 mL 5α-Cholestane internal standard solution and 10 mL of distilled water to each centrifuge tube, the cap was closed and stirred vigorously for 30 seconds, and this was centrifuged at 3000 rpm for 2 minutes. The heptane layer of the upper layer was taken as a test solution for gas chromatograph (Shimadzu GC-2010) measurement. The analysis conditions for analyzing the cholesterol level are shown in Table 3 below.

ItemsItems ConditionsConditions InstrumentInstrument Shimadzu GC2010Shimadzu GC2010 ColumnColumn HP-5(50m×0.25mm)HP-5(50m×0.25mm) Carrier gasCarrier gas N2 N 2 DetectorDetector FIDFID Flow rateFlow rate 2(㎖/min)2 (ml/min) Injection temp.Injection temp. 250℃250℃ Column temp.Column temp. 190℃ for 2min, 20℃/min(Rate), 230℃ for 3min,
40℃/min(Rate), 255℃ for 25min
190℃ for 2min, 20℃/min(Rate), 230℃ for 3min,
40℃/min(Rate), 255℃ for 25min
Detector temp.Detector temp. 300℃300 Injection volumeInjection volume 1㎕1 μl

7. 무기질 및 중금속 측정 실험7. Inorganic and heavy metal measurement experiments

시료의 조제는 습식 분해법을 이용하여 시료 0.5g 내외를 정밀하게 측정하여 65% HNO3 5mL와 30% H2O2 1mL를 teflon bottle에 담은 후 이를 전처리 시험용액으로 사용하였다. 전처리 방법은 microwave digestion system(Ethos-1600, USA)을 이용하여 최고 550W로 총 30분간 산 분해를 실시하였다. 전처리 과정을 거친 시료용액을 0.45 μm PTFE filter로 여과하여 분석시료로 사용하였다. 무기질 및 중금속정량은 정량은 Inductively Coupled Plasma spectrometer (SHIMADZU ICPE 9000, Japan)를 사용하여 분석하였으며 분석조건은 표 4와 같다. 모든 시약과 증류수는 무기질 분석용을 사용하였다.The preparation of the sample was precisely measured around 0.5 g of the sample using a wet decomposition method, and 5 mL of 65% HNO 3 and 1 mL of 30% H 2 O 2 were placed in a teflon bottle and used as a pretreatment test solution. The pre-treatment method was acid digestion using microwave digestion system (Ethos-1600, USA) at a maximum of 550 W for 30 minutes. The sample solution that had been subjected to the pre-treatment was filtered with a 0.45 μm PTFE filter and used as an analysis sample. Quantitative analysis of inorganic and heavy metals was carried out using an Inductively Coupled Plasma spectrometer (SHIMADZU ICPE 9000, Japan). All reagents and distilled water were used for mineral analysis.

InstrumentInstrument ConditionsConditions Radio Frequency PowerRadio Frequency Power 1.20 kW1.20 kW Plasma GasPlasma Gas 10.0 L/min10.0 L/min Auxiliary GasAuxiliary Gas 0.60 L/min0.60 L/min Carrier GasCarrier Gas 0.70 L/min0.70 L/min Wave length(㎚)Wave length(nm) NaNa 589.592589.592 PbPb 220.353220.353 CdCD 214.438214.438

실험결과Experiment result

상기의 방법으로 실시한 영양소(조단백질, 조지방, 조회분, 탄수화물, 지방산, 유리당, 콜레스테롤 및 무기질) 및 중금속 측정 실험 결과는 하기 표 5와 같다. 본 실험은 (재)경북테크노파크 대구한의대특화센터 효능검증원에 의뢰하여 진행하였다.The nutrients (crude protein, crude fat, ash, carbohydrate, fatty acid, free sugar, cholesterol and minerals) and heavy metals measured by the above method are shown in Table 5 below. This experiment was conducted by requesting the Kyungpook Techno Park Daegu Oriental Medical Center Efficacy Verification Center.

시험항목Test Items 함량content 열량calorie 40.33 (Kcal/100g)40.33 (Kcal/100g) 나트륨salt 353.93 (mg/100g)353.93 (mg/100g) 탄수화물carbohydrate 7.67 (g/100g)7.67 (g/100g) 당류sugars 0.15 (g/100g)0.15 (g/100g) 지방Fat 0.19 (g/100g)0.19 (g/100g) 트랜스지방trans fat 0 (g/100g)0 (g/100g) 포화지방Saturated fat 0.03 (g/100g)0.03 (g/100g) 콜레스테롤cholesterol 0 (mg/100g)0 (mg/100g) 단백질protein 1.98 (g/100g)1.98 (g/100g) 납(Pb)Lead (Pb) 0.05 (mg/Kg)0.05 (mg/Kg) 카드뮴(Cd)Cadmium (Cd) 0.07 (mg/kg)0.07 (mg/kg) 칼슘(Ca)Calcium (Ca) 161.96 (mg/100g)161.96 (mg/100g) 구리(Cu)Copper (Cu) 불검출Non-detection 철(Fe)Iron (Fe) 0.78 (mg/100g)0.78 (mg/100g) 칼륨(K)Potassium (K) 564.55 (mg/100g)564.55 (mg/100g) 마그네슘(Mg)Magnesium (Mg) 85.98 (mg/100g)85.98 (mg/100g) 인(P)Phosphorus (P) 139.68 (mg/100g)139.68 (mg/100g) 아연(Zn)Zinc (Zn) 0.43 (mg/100g)0.43 (mg/100g)

구성 아미노산 및 유리 아미노산 측정 실험Composition amino acid and free amino acid measurement experiment

1. 구성 아미노산 측정 실험1. Composition amino acid measurement experiment

동결건조한 대황 추출물 50mg에 6N HCl을 첨가하여 밀봉한다. 밀봉한 샘플을 110℃에서 24시간동안 가수분해 후, 밀봉을 해제하여 80℃에서 24시간동안 열을 가하여 건조시킨다. 건조 완료된 샘플의 농도에 따라서 0.02N HCl로 희석한 후 0.45um 필터를 이용하여 filtration 후 아미노산 자동 분석기에 injection하여 구성 아미노산을 측정하였다. 분석 조건은 하기 표 6과 같다.6N HCl is added to 50 mg of lyophilized rhubarb extract and sealed. The sealed sample was hydrolyzed at 110° C. for 24 hours, then the seal was released and dried by heating at 80° C. for 24 hours. After diluting with 0.02N HCl according to the concentration of the dried sample, filtration using a 0.45um filter and injection into the amino acid automatic analyzer to measure the constituent amino acids. Analysis conditions are shown in Table 6 below.

ColumnColumn Ion exchangeIon exchange PumpPump Pressure 0~19.6Mpa Flow Rate 0.05~0.99㎖/minPressure 0~19.6Mpa Flow Rate 0.05~0.99ml/min Auto samplerAuto sampler 200vials200vials Injection VolumeInjection Volume 1~100㎕1~100μl Reaction UnitReaction Unit Reaction Column(135℃)Reaction Column(135℃) Detector Detector Wavelength 570㎚. 440㎚Wavelength 570 nm. 440nm

2. 유리 아미노산 측정 실험2. Free amino acid measurement experiment

동결건조한 대황 추출물 0.1g에 5% trichloroacetic acid를 첨가하여 균질화한 후 원심분리기를 이용하여 10,000rpm에서 10분간 원심분리하여 상층액을 채취한다. 채취한 상층액을 0.45um 필터를 이용하여 filtration 후 아미노산 자동 분석기에 injection하여 유리 아미노산을 측정하였다. 분석 조건은 상기 표 6과 같다.After homogenization by adding 5% trichloroacetic acid to 0.1 g of lyophilized rhubarb extract, centrifuge at 10,000 rpm for 10 minutes using a centrifuge to collect the supernatant. The collected supernatant was filtered using a 0.45um filter, and then injected into an automatic amino acid analyzer to measure free amino acids. Analysis conditions are shown in Table 6 above.

실험결과Experiment result

1. 구성 아미노산 측정 결과1. Composition amino acid measurement result

대황 추출물에 대해 구성 아미노산 함량을 측정한 결과는 다음 표 7과 같다. 구성 아미노산 함량 측정 결과, glutamic acid, alanine 및 proline의 함량이 높은 것으로 확인되었다.Table 7 shows the results of measuring the amino acid content of the rhubarb extract. As a result of measurement of the content of the constituent amino acids, it was confirmed that the contents of glutamic acid, alanine and proline were high.

구성 아미노산 종류Composition amino acid type 함량 (mg/g)Content (mg/g) aspartic acidaspartic acid 5.6665.666 threoninethreonine 3.2233.223 serineserine 2.8102.810 glutamic acidglutamic acid 30.11230.112 glycineglycine 3.3313.331 alaninealanine 22.14022.140 cystinecystine 0.8200.820 valinevaline 3.4353.435 methioninemethionine 1.3851.385 isoleucineisoleucine 2.4172.417 leucineleucine 4.5384.538 tyrosinetyrosine 2.7002.700 phenylalaninephenylalanine 4.0964.096 lysinelysine 3.9783.978 ammoniaammonia 3.7683.768 histidinehistidine 1.0981.098 argininearginine 2.7302.730 prolineproline 19.37719.377 total amino acidtotal amino acid 113.858 113.858 ND=Not DetectedND=Not Detected

2. 유리 아미노산 측정 결과2. Free amino acid measurement results

대황 추출물에 대해 유리 아미노산 함량을 측정한 결과는 다음 표 8과 같다. 유리 아미노산 함량 측정 결과, proline, cystathionine, clutamic acid의 함량이 높은 것으로 확인되었다.The results of measuring the free amino acid content for rhubarb extract are shown in Table 8 below. As a result of measuring the free amino acid content, it was confirmed that the content of proline, cystathionine, and clutamic acid was high.

유리 아미노산 종류Free amino acid type 함량 (ug/g)Content (ug/g) phosphoserinephosphoserine 230.846230.846 taurinetaurine NDND phospho ethanol aminephospho ethanol amine 181.284181.284 ureaurea NDND aspartic acidaspartic acid 392.447392.447 threoninethreonine 124.128124.128 serineserine 186.032186.032 glutamic acidglutamic acid 877.961877.961 sarcosinesarcosine NDND α-amino adipic acidα-amino adipic acid NDND glycineglycine 64.40064.400 alaninealanine NDND citrullinecitrulline NDND α-amino-n-butyric acidα-amino-n-butyric acid NDND valinevaline 202.537202.537 cystinecystine 55.93355.933 methioninemethionine 25.65325.653 cystathioninecystathionine 565.690565.690 isoleucineisoleucine 153.545153.545 leucineleucine 108.290108.290 tyrosinetyrosine 100.030100.030 phenylalaninephenylalanine 89.78389.783 β-alanineβ-alanine 40.43840.438 β-amino isobutyric acidβ-amino isobutyric acid 36.18936.189 γ-amino-n-butyric acidγ-amino-n-butyric acid 3.3183.318 ethanol amineethanol amine 59.84859.848 hydroxylysinehydroxylysine 15.18415.184 ornithineornithine 25.65125.651 lysinelysine 103.063103.063 1-methylhistidine1-methylhistidine NDND histidinehistidine 18.97618.976 3-methylhistidine3-methylhistidine NDND anserineanserine NDND carnosinecarnosine NDND argininearginine 340.833340.833 hydroxy prolinehydroxy proline 5.1325.132 prolineproline 7369.8337369.833 total free amino acidtotal free amino acid 11.37711.377 ND=Not DetectedND=Not Detected

지방산 조성 측정 실험Fatty acid composition measurement experiment

지방 추출에 앞서 검체(대황추출물)를 균질화 하였다. 균질화된 검체를 약 100~200 mg의 지방을 포함하는 양으로 정확히 칭량하여 마조니어(Mojonnier)관에 넣고 약 100 mg의 피로갈롤을 첨가한 후, 2 mL의 내부표준용액을 첨가하였다. 마조니어(Mojonnier)관에 끓임쪽을 넣고 2 mL 에탄올을 첨가하여 전체 검체가 잘 섞일 때까지 혼합한다. 8.3 M 염산용액 10 mL을 넣고 섞었다. 마조니어(Mojonnier)관의 마개를 고무줄 혹은 테프론테이프 등으로 밀봉한 후, 70~80℃의 수조에서 적당한 속도로 교반하면서 40분간 분해하였다. 마조니어(Mojonnier)관의 벽면에 붙어있는 입자들이 잘 혼합될 수 있도록 매 10분마다 교반기로 혼합하였다. 분해 후, 에탄올을 첨가하여 채운 후 부드럽게 섞었다. 준비된 마조니어(Mojonnier)관의 분해물에 25 mL 디에틸에테르를 첨가하고 마개를 한 후 5분간 진탕하여 추출하였다. 에테르 혼합 추출용매로 마개를 씻고 25 mL의 무수 석유에테르를 추가하여 5분간 다시 진탕 추출하고 600 rpm에서 5분간 원심분리 하였다. 에테르 혼합 추출용매로 마개를 씻고 150 mL 비이커에 에테르 층을 분액한 후 증발시키기 위해 질소를 사용하여 35~40℃ 수조에서 에테르를 천천히 증발 시켰다. 2~3 mL 클로로포름과 2~3 mL 디에틸에테르로 추출한 지방을 녹여 15 mL 시험관으로 옮긴 후, 40℃ 수조에서 질소 농축하고 2.0 mL 7% 트리플루오로보란메탄올 용액과 1.0 mL의 톨루엔을 첨가하였다. 테프론/실리콘 재질의 마개로 잘 밀봉하여 100℃ 오븐에서 45분간 가열한 후 실온으로 냉각하였다. 5.0 mL 증류수, 1.0 mL 헥산 및 약 1.0 g 무수 황산나트륨를 첨가한 후 진탕하여 정치하고 분리된 상층액을 취하여 약 1.0 g의 무수 황산나트륨을 담은 다른 바이알(Vial)에 넣고 탈수한 후 시험용액으로 하였다.The sample (rhubarb extract) was homogenized prior to fat extraction. The homogenized sample was accurately weighed in an amount containing about 100-200 mg of fat, placed in a Majonnier tube, and about 100 mg of pyrogallol was added, and then 2 mL of an internal standard solution was added. Add the boiled side to the Majonnier tube and add 2 mL of ethanol to mix until the whole sample is well mixed. Add 10 mL of 8.3 M hydrochloric acid solution and mix. The stopper of the Majonnier tube was sealed with a rubber band or Teflon tape, and then decomposed for 40 minutes while stirring at an appropriate speed in a water bath at 70 to 80°C. The stirrer was mixed every 10 minutes so that the particles attached to the wall surface of the Majonnier tube were well mixed. After decomposition, ethanol was added to fill and gently mixed. 25 mL of diethyl ether was added to the decomposed product of the prepared Majonnier tube, the mixture was capped and shaken for 5 minutes to extract. The stopper was washed with an ether mixed extraction solvent, 25 mL of anhydrous petroleum ether was added, shake-extracted again for 5 minutes, and centrifuged at 600 rpm for 5 minutes. After washing the stopper with an ether mixed extraction solvent, the ether layer was separated in a 150 mL beaker, and then the ether was slowly evaporated in a 35-40° C. water bath using nitrogen to evaporate. The fat extracted with 2-3 mL chloroform and 2-3 mL diethyl ether was dissolved, transferred to a 15 mL test tube, concentrated in nitrogen in a 40° C. water bath, and 2.0 mL 7% trifluoroboranmethanol solution and 1.0 mL toluene were added. . Sealed well with a Teflon/silicon stopper, heated in an oven at 100° C. for 45 minutes, and then cooled to room temperature. After adding 5.0 mL of distilled water, 1.0 mL of hexane and about 1.0 g of anhydrous sodium sulfate, shaking and standing, the separated supernatant was taken, placed in another vial containing about 1.0 g of anhydrous sodium sulfate, dehydrated, and used as a test solution.

실험결과Experiment result

지방산 조성 측정 결과는 다음 표 9에 나타내었다.Fatty acid composition measurement results are shown in Table 9 below.

지방산 종류Fatty acid type 검체중 지방산
(g/100g)
Fatty acid in the sample
(g/100g)
Methyl butyrate(C4:0)Methyl butyrate(C4:0) 0.00000.0000 Methyl hexanoate(C6:0)Methyl hexanoate(C6:0) 0.00000.0000 Methyl octanoate(C8:0)Methyl octanoate(C8:0) 0.00000.0000 Methyl decanoate(C10:0)Methyl decanoate(C10:0) 0.00000.0000 Methyl undecanoate(C11:0)Methyl undecanoate(C11:0) 0.00000.0000 Methyl laurate(C12:0)Methyl laurate(C12:0) 0.00000.0000 Methyl tridecanoate(C13:0)Methyl tridecanoate(C13:0) 0.00000.0000 Methyl myristate(C14:0)Methyl myristate(C14:0) 0.00510.0051 Myristoleic acid methyl ester(C14:1)Myristoleic acid methyl ester (C14:1) 0.00000.0000 Methyl pentadecanoate(C15:0)Methyl pentadecanoate(C15:0) 0.00000.0000 Cis-10-pentadecanoic acid methyl ester(C15:1)Cis-10-pentadecanoic acid methyl ester (C15:1) 0.00000.0000 Methyl palmitate(C16:0)Methyl palmitate(C16:0) 0.01520.0152 Methyl palmitoleate(C16:1)Methyl palmitoleate (C16:1) 0.00470.0047 Methyl heptadecanoate(C17:0)Methyl heptadecanoate(C17:0) 0.00000.0000 Cis-10-heptadecanoic acid methyl ester(C17:1)Cis-10-heptadecanoic acid methyl ester (C17:1) 0.00000.0000 Methyl stearate(C18:0)Methyl stearate(C18:0) 0.00000.0000 Trans-9-elaidic acid methyl ester(C18:1n9t)Trans-9-elaidic acid methyl ester(C18:1n9t) 0.00000.0000 Cis-9-oleic acid methyl ester(C18:1n9c)Cis-9-oleic acid methyl ester (C18:1n9c) 0.00900.0090 Linolelaidic acid methyl ester(C18:2n6t)Linolelaidic acid methyl ester(C18:2n6t) 0.00000.0000 Methyl linoleate(C18:2n6c)Methyl linoleate(C18:2n6c) 0.00330.0033 Methyl arachidate(C20:0)Methyl arachidate(C20:0) 0.00000.0000 Gamma-linolenic acid methyl ester(C18:3n6)Gamma-linolenic acid methyl ester (C18: 3n6) 0.00000.0000 Methyl cis-11 eicosanoate(C20:1)Methyl cis-11 eicosanoate (C20:1) 0.00000.0000 Methyl linolenate(C18:3n3)Methyl linolenate(C18:3n3) 0.00440.0044 Methyl heneicosanoate(C21:0)Methyl heneicosanoate(C21:0) 0.00000.0000 Cis-11,14-eicosadienoic acid methyl ester(C20:2)Cis-11,14-eicosadienoic acid methyl ester(C20:2) 0.00660.0066 Methyl behenate(C22:0)Methyl behenate(C22:0) 0.00000.0000 cis-8,11,14-eicosatrienoic acid methyl ester(C20:3n6)cis-8,11,14-eicosatrienoic acid methyl ester(C20:3n6) 0.00000.0000 Methyl erucate(C22:1n9)Methyl erucate(C22:1n9) 0.00000.0000 Cis-11,14,17-eicosatrenoic acid methyl ester(C20:3n3)Cis-11,14,17-eicosatrenoic acid methyl ester(C20:3n3) 0.00000.0000 Methyl cis-5,,8,11,14-eicosatetraenoic acid
methyl ester(C20:4n6)
Methyl cis-5,,8,11,14-eicosatetraenoic acid
methyl ester(C20:4n6)
0.00000.0000
Methyl trcosanoate(C23:0)Methyl trcosanoate(C23:0) 0.01230.0123 cis-13,16-docosadienoic acid methyl ester(C22:2)cis-13,16-docosadienoic acid methyl ester(C22:2) 0.00000.0000 Methyl lignocerate(C24:0)Methyl lignocerate(C24:0) 0.00000.0000 Methyl cis-5,8,11,14,17-eicosapentaenoate(C20:5n3)Methyl cis-5,8,11,14,17-eicosapentaenoate(C20:5n3) 0.00460.0046 Methyl nervonate(C24:1)Methyl nervonate(C24:1) 0.00000.0000 Cis-4,7,10,13,16,19-docosahexaenoic acid
methyl ester(C22:6n3)
Cis-4,7,10,13,16,19-docosahexaenoic acid
methyl ester(C22:6n3)
0.00000.0000

항산화 효과 실험Antioxidant effect experiment

1. DPPH radical 소거능1. DPPH radical scavenging ability

실험군으로는 대황 열수추출물 및 함량별 에탄올추출물을 각각 50% ethanol에 1 g/10 ㎖의 농도로 희석하여 진행하였다. 본 실험은 항산화 분석법 중 Blois의 방법에 따라 측정하였고(Blois, 1958), ethanol에 용해시킨 0.1 mM DPPH (2,2-diphenyl-1-picrylhydrazyl, Sigma, USA) 900 ㎕와 각 실험군 100 ㎕를 E.P. tube에 넣고 10분간 암반응 시킨 후 UV spectrophotometer (TECAN, Mannedorf, Switzerland)를 이용하여 517 nm에서 측정하였으며, 양성대조군으로는 ascorbic acid (Sigma, USA)을 사용하였고, 농도는 1 ㎎/㎖로 측정하였다. 실험군의 항산화능은 시료첨가구와 무첨가구의 흡광도를 구하여 계산하였다.In the experimental group, rhubarb hot water extract and ethanol extract by content were diluted with 50% ethanol to a concentration of 1 g/10 ml. This experiment was measured according to the method of Blois in the antioxidant assay (Blois, 1958), 900 µl of 0.1 mM DPPH (2,2-diphenyl-1-picrylhydrazyl, Sigma, USA) dissolved in ethanol, and 100 µl of each experimental group was E.P. After putting into a tube and reacting for 10 minutes, it was measured at 517 nm using a UV spectrophotometer (TECAN, Mannedorf, Switzerland), ascorbic acid (Sigma, USA) was used as a positive control, and the concentration was measured at 1 mg/ml. . The antioxidant capacity of the experimental group was calculated by obtaining the absorbance of the sample-added and no-added.

2. ABTS radical 소거능2. ABTS radical scavenging ability

실험군으로는 대황 열수추출물 및 함량별 에탄올추출물을 각각 50% ethanol에 1 g/10 ㎖의 농도로 희석하여 진행하였다. 본 실험은 ABTS+ decolorization assay법을 응용하여 측정하였고, 증류수에 용해한 7.4 mM ABTS (Sigma, USA)와 2.6 mM potassium persulphate를 1:1로 섞어 12-16시간 동안 암소에 방치한 radical stock solution 1 ㎖에 각 실험군 50 ㎕을 가하여 60분간 반응시킨 후 UV spectrophotometer (TECAN, Mannedorf, Switzerland)를 이용하여 흡광도를 측정하였다. 양성대조군으로는 ascorbic acid (Sigma, USA) 1 ㎎/㎖와 Trolox (Sigma, USA) 1 mM을 사용하였고, 실험군의 항산화능은 시료첨가구와 무첨가구의 흡광도를 구하여 계산하였다.In the experimental group, rhubarb hot water extract and ethanol extract by content were diluted with 50% ethanol to a concentration of 1 g/10 ml. This experiment was measured by applying the ABTS+ decolorization assay, and mixed with 7.4 mM ABTS (Sigma, USA) dissolved in distilled water and 2.6 mM potassium persulphate 1:1 in 1 ml of radical stock solution left in the cow for 12-16 hours. After 50 μl of each experimental group was added and reacted for 60 minutes, absorbance was measured using a UV spectrophotometer (TECAN, Mannedorf, Switzerland). As a positive control, ascorbic acid (Sigma, USA) 1 mg/ml and Trolox (Sigma, USA) 1 mM were used, and the antioxidant capacity of the experimental group was calculated by obtaining the absorbance of the sample and no additives.

3. SOD 유사활성 측정3. SOD-like activity measurement

실험군으로는 대황 열수추출물 및 함량별 에탄올추출물을 각각 Tris-HCl buffer(pH 8.5) 0.5 g/10 ㎖의 농도로 희석하여 진행하였다. 본 실험은 Marklund등의 방법에 따라 측정하였고, 각 실험군 0.2 ㎖에 Tris-HCl buffer(pH 8.5) 3㎖와 증류수에 용해한 7.2 mM pyrogallol 0.2 ㎖을 가하여 25℃에서 10분간 방치 후, 1N HCl 1 ㎖로 반응을 정지시킨 후 UV spectrophotometer (TECAN, Mannedorf, Switzerland)를 이용하여 420 nm에서 흡광도를 측정하였다. 실험군의 항산화능은 시료첨가구와 무첨가구의 흡광도를 구하여 계산하였다.In the experimental group, rhubarb hot water extract and ethanol extract by content were each diluted to a concentration of 0.5 g/10 mL of Tris-HCl buffer (pH 8.5). This experiment was measured according to the method of Marklund et al., and 0.2 ml of Tris-HCl buffer (pH 8.5) and 0.2 ml of 7.2 mM pyrogallol dissolved in distilled water were added to 0.2 ml of each experimental group and left at 25°C for 10 minutes, followed by 1N HCl 1 ml After the reaction was stopped, the absorbance was measured at 420 nm using a UV spectrophotometer (TECAN, Mannedorf, Switzerland). The antioxidant capacity of the experimental group was calculated by obtaining the absorbance of the sample-added and no-added.

4. Superoxide dismutase (SOD) 효소활성4. Superoxide dismutase (SOD) enzyme activity

세포실험 : 한국세포주은행(KCLB; Korean Cell Bank)에서 human hepatocellular liver carcinoma cell line을 구입하여 10% FBS(fetal bovine serum)과 penicillin-streptomycin이 첨가한 Dulbeccos modified Eaglesmedium (DMEM, Sigma, USA)를 배지를 사용하여 37℃ 온도에서 5% CO2 상태로 배양하였고, plate에 계대 후 세포가 일정수준의 confluency에 도달한 상태에서 대황 열수추출물 및 함량별 에탄올추출물을 100 ㎍/㎖의 농도로 약물 전처리후 tBHP (Sigma, USA) 100 uM을 처치한 후 반응시켰다.Cell experiment: Human hepatocellular liver carcinoma cell line was purchased from the Korean Cell Bank (KCLB) and cultured with 10% FBS (fetal bovine serum) and Dulbeccos modified Eaglesmedium (DMEM, Sigma, USA) added with penicillin-streptomycin After incubation with 5% CO 2 at a temperature of 37° C., after passage on the plate, after the cells reach a certain level of confluency, the rhubarb hot water extract and ethanol extract by content are pretreated with a concentration of 100 μg/ml. tBHP (Sigma, USA) was reacted after treating 100 uM.

SOD assay : Superoxide dismutase (SOD) 활성도 측정은 Cayman SOD assay kit를 사용하여 450 nm에서 측정하였고, 실험군의 SOD 효소활성능은 시료첨가구와 무첨가구의 흡광도를 구하여 계산하였다.SOD assay: Superoxide dismutase (SOD) activity was measured at 450 nm using the Cayman SOD assay kit, and the SOD enzyme activity of the experimental group was calculated by obtaining the absorbance of the sample and no additives.

5. MTT assay를 통한 세포생존률 확인5. Confirmation of cell viability through MTT assay

세포실험 : 한국세포주은행(KCLB; Korean Cell Bank)에서 human hepatocellular liver carcinoma cell line을 구입하여 10% FBS(fetal bovine serum)과 penicillin-streptomycin이 첨가한 Dulbeccos modified Eaglesmedium (DMEM, Sigma, USA)를 배지를 사용하여 37℃ 온도에서 5% CO2 상태로 배양하였고, plate에 계대 후 세포가 일정수준의 confluency에 도달한 상태에서 대황 열수 및 ethanol 함량별 추출물을 100 ㎍/㎖의 농도로 약물 전처리후 tBHP (Sigma, USA) 100 uM을 처치한 후 반응시켰다.Cell experiment: Human hepatocellular liver carcinoma cell line was purchased from the Korean Cell Bank (KCLB) and cultured with 10% FBS (fetal bovine serum) and Dulbeccos modified Eaglesmedium (DMEM, Sigma, USA) added with penicillin-streptomycin The cells were cultured in a state of 5% CO 2 at a temperature of 37° C., and after passage on a plate, the extracts according to rhubarb hot water and ethanol content at a concentration of 100 μg/ml after cell passage reached a certain level of tBHP (Sigma, USA) 100 uM was treated and reacted.

MTT assay : 배양 후 MTT 시약을 최종 농도가 0.5 mg/ml 되도록 각 well에 넣고 37℃, 5% CO2 incubator에서 4시간 동안 배양한 후 배양액을 버리고 DMSO를 처리하여 formazan을 용해시켜 UV spectrophotometer (TECAN, Mannedorf, Switzerland)를 이용하여 570 nm에서 흡광도를 측정하였다.MTT assay: After incubation, add MTT reagent to each well so that the final concentration is 0.5 mg/ml, incubate for 4 hours at 37°C, 5% CO 2 incubator, discard the culture medium, treat DMSO and dissolve formazan to dissolve formazan, UV spectrophotometer (TECAN , Mannedorf, Switzerland) was measured at 570 nm.

실험결과Experiment result

1. DPPH radical 소거능 측정 결과1. DPPH radical scavenging ability measurement result

대황 추출물의 DPPH radical 소거능을 확인한 결과, 양성대조군인 ascorbic acid 1 ㎎/㎖ 기준으로 대황 열수추출물과 10% 대황 에탄올추출물, 20% 대황 에탄올추출물을 제외한 나머지 함량에서 높은 항산화 활성을 나타내었다. DPPH radical 소거능 분석 결과는 하기 도 1에 나타내었다. As a result of confirming DPPH radical scavenging ability of rhubarb extract, it showed high antioxidant activity at the rest of the contents except for rhubarb hot water extract, 10% rhubarb ethanol extract, and 20% rhubarb ethanol extract, based on 1 mg/mL ascorbic acid, a positive control. DPPH radical scavenging activity analysis results are shown in Figure 1 below.

2. ABTS radical 소거능 측정 결과2. ABTS radical scavenging ability measurement result

대황 추출물의 ABTS scavenging을 확인한 결과, 양성대조군인 ascorbic acid 1 ㎎/㎖와 Trolox 1 mM 기준으로 대황 열수추출물 및 에탄올 함량별 대황 에탄올추출물에서 모두 높은 항산화 활성을 나타내는 것을 알 수 있다. ABTS radical 소거능 분석 결과는 하기 도 2에 나타내었다.As a result of confirming ABTS scavenging of the rhubarb extract, it can be seen that both rhubarb hot water extract and rhubarb ethanol extract by ethanol content showed high antioxidant activity based on 1 mg/mL of ascorbic acid and 1 mM of Trolox, which are positive controls. The results of ABTS radical scavenging activity analysis are shown in FIG. 2 below.

3. SOD 유사활성 측정 결과3. SOD-like activity measurement result

대황 추출물의 SOD 유사활성을 확인한 결과, 대황 열수추출물 및 100% 대황 에탄올추출물을 제외한 나머지 함량에서 50% 이상의 항산화 활성을 보여주며 특히, 50% 및 70~90% 에탄올 함량 추출물에서 높은 항산화 활성을 나타낸다. SOD 유사활성 측정 결과는 하기 도 3에 나타내었다.As a result of confirming the SOD-like activity of rhubarb extract, it shows more than 50% antioxidant activity in the remaining contents except for rhubarb hot water extract and 100% rhubarb ethanol extract, and in particular, exhibits high antioxidant activity in 50% and 70-90% ethanol content extracts . SOD-like activity measurement results are shown in Figure 3 below.

4. Superoxide dismutase (SOD) 효소활성 측정 결과4. Superoxide dismutase (SOD) enzyme activity measurement result

대황 열수추출물 및 에탄올 함량별 추출물에서 SOD 효소활성능은 대조군과 비교하여 유사하거나 높은 활성을 나타냈으며, tBHP 단독 처리시 SOD 효소활성이 대조군에 비해 80.99%로 감소한 반면 tBHP와 실험군을 같이 처리한 경우 단독 처리군과 비교하여 감소하는 경향을 나타내었으나 tBHP 단독군과 비교시 효소활성이 증가하는 것을 알 수 있으며 특히 열수 및 10%, 70-90% 에탄올 함량 추출물에서 높은 효소활성을 나타내었다. Superoxide dismutase (SOD) 효소활성 측정 결과는 하기 도 4에 나타내었다.In the extract of rhubarb hot water extract and ethanol content, SOD enzyme activity showed similar or high activity compared to the control group.When tBHP treatment alone, the SOD enzyme activity decreased to 80.99% compared to the control group, whereas when treated with tBHP and the experimental group Although it showed a tendency to decrease compared to the single treatment group, it was found that the enzyme activity increased when compared to the tBHP alone group, and particularly, it showed high enzyme activity in hot water and 10%, 70-90% ethanol content extract. The results of measuring superoxide dismutase (SOD) enzyme activity are shown in FIG. 4 below.

5. MTT assay를 통한 세포생존률 확인 결과5. Cell viability confirmation result through MTT assay

대조군과 비교하여 대황 60, 100% 에탄올 추출물에서 세포독성을 나타냈으며, tBHP와 같이 처치 시 60, 100% 에탄올 추출물에서 세포독성이 높게 나타났다. MTT assay를 통한 세포생존률 확인 결과는 하기 도 5에 나타내었다.Compared to the control group, cytotoxicity was shown in rhubarb 60, 100% ethanol extract, and when treated with tBHP, cytotoxicity was high in 60, 100% ethanol extract. The results of confirming the cell viability through the MTT assay are shown in FIG. 5 below.

항염증 효과 실험Anti-inflammatory effect experiment

1. MTT assay에 의한 세포 독성 측정1. Measurement of cytotoxicity by MTT assay

세포 생존율 측정을 위해 사용된 macrophage cell(RAW 264.7)은 ameriacan type culture collection(Manassas, USA)에서 구입하였다. 세포 배양 배지는 10% FBS와 1% penicillin/streptomycin(100 unit/mL)의 비율로 혼합한 DMEM배지를 사용하였며, 37℃, 5% CO2 incubator에 적응시켜 계대 배양하였다. RAW 264.7을 96-well plate에 5×104 cells/well이 되게 0.18 mL 분주하고, 시료를 농도 별로 제조하여 0.02 mL 첨가 후 37℃, 5% CO2 incubator에서 24시간 배양하였다. 대황 70%ethanol 추출물은 10, 25, 50, 100, 250, 500, 1000 μg/mL 농도별로 24시간 동안 처리 한 후 2.5mg/mL 농도로 제조한 MTT 용액을 0.02 mL 첨가하여 4시간 동안 배양시킨다. 그 후 배양액을 제거하고 각 well 당 DMSO(Dimethyl Sulfoxide, DUSAN) 0.1 mL를 가하여 실온에서 30분간 반응 시킨 뒤 ELISA reader로 540nm에서 흡광도를 측정하였다. 세포 독성 측정은 시료용액 첨가군과 무첨가군의 흡광도 감소율로 나타내었다.Macrophage cells (RAW 264.7) used to measure cell viability were purchased from the ameriacan type culture collection (Manassas, USA). As the cell culture medium, DMEM medium mixed at a ratio of 10% FBS and 1% penicillin/streptomycin (100 unit/mL) was used, and the cells were subcultured by adapting to a 37°C, 5% CO 2 incubator. RAW 264.7 was dispensed into a 96-well plate at 0.18 mL so as to be 5×104 cells/well, and samples were prepared for each concentration, and 0.02 mL was added, followed by incubation at 37° C. in a 5% CO2 incubator for 24 hours. Rhubarb 70%ethanol extract is treated for 10 hours at concentrations of 10, 25, 50, 100, 250, 500, and 1000 μg/mL, and then incubated for 4 hours by adding 0.02 mL of MTT solution prepared at a concentration of 2.5 mg/mL. . Thereafter, the culture solution was removed, and 0.1 mL of DMSO (Dimethyl Sulfoxide, DUSAN) per well was reacted for 30 minutes at room temperature, and absorbance at 540 nm was measured using an ELISA reader. Cytotoxicity was measured as a decrease in absorbance between the sample solution added group and the non-added group.

2. Nitric oxide 저해율 측정2. Nitric oxide inhibition rate measurement

Nitric oxide(NO) 생성량은 세포배양액 중에 존재하는 NO를 griess reagent를 이용하여 측정하였다. 96 well plate에 세포주 RAW 264.7을 5 x 104 cells/well이 되도록 seeding 하고 37 ℃, 5% CO2 incubator에서 24시간 동안 배양시킨다. 그 뒤에 배양액을 혈청 무첨가 DMEM 배지로 교환하고 염증 반응을 유도하기위해 lipopolysaccharide (LPS)를 1 ppm/well 이 되도록 처리하고 각 대황 70% 추출물은 10, 25, 50, 100, 250, 500, 1000 μg/mL 농도별로 처리한뒤 37 ℃, 5% CO2 incubator에서 24시간 동안 배양시킨다. 그 뒤에 새로운 96 well plate에 세포 배양액을 100 μL 옮기고 griess reagent를 100 μL 첨가 하여 상온에서 5 min 동안 반응시킨 뒤에 540 nm 에서 흡광도를 측정하여 결과를 계산하였다. The amount of Nitric oxide (NO) production was measured using the griess reagent for NO present in the cell culture medium. Seed the cell line RAW 264.7 to 5 x 10 4 cells/well in a 96 well plate and incubate for 24 hours in a 37°C, 5% CO 2 incubator. Subsequently, the culture medium is exchanged with serum-free DMEM medium and treated with lipopolysaccharide (LPS) to 1 ppm/well to induce an inflammatory reaction, and each rhubarb 70% extract is 10, 25, 50, 100, 250, 500, 1000 μg After treating by /mL concentration, incubate for 24 hours in a 37°C, 5% CO 2 incubator. Then, 100 μL of the cell culture was transferred to a new 96 well plate, and 100 μL of griess reagent was added to react for 5 min at room temperature, and absorbance was measured at 540 nm to calculate the result.

3. Western blot을 통한 iNOS, COX-2 단백질 발현 측정3. Measurement of iNOS and COX-2 protein expression through Western blot

iNOS와 COX-2 단백질 발현을 확인하기 위하여 6 well plate에 세포주 RAW 264.7을 2 x 105 cells/well이 되도록 seeding 하고 37 ℃, 5% CO2 incubator에서 24시간 동안 배양시킨다. 그 뒤에 배양액을 혈청 무첨가 DMEM 배지로 교환한 후 세포의 염증 반응을 유도하기 위하여 lipopolysaccharide(LPS)를 1 ppm/well 이 되도록 처리하고 각 시료용액을 농도별로 처리한뒤 37 ℃, 5% CO2 incubator에서 24시간 동안 배양시킨다. 그 뒤에 배지를 제거하고 PBS로 1회 세척 후 phosphatase 와 protease inhibitor를 각각 0.1% 함유시킨 RIPA 버퍼를 60 μL/well로 처리하여 세포를 용해시키고 원심분리기를 이용하여 -4 ℃, 15,000 rpm에서 15 min 동안 원심분리 시키고 얻은 상층액을 새 튜브에 옮긴다. 그 이후, bradford assay로 단백질의 양을 정량하고 power supply electrophoresis 기기를 이용하여 10% SDS-PAGE로 질량별 분리시키고 PVDF membrane에 옮긴다. membrane은 digital reciprocating shaker 기기를 이용하여 5% skin milk 2시간, primary antibody 2 시간, TBST solution 10분 (3회 반복), secondary antibody 1 시간, TBST solution 10 분 (3회 반복) 순의 blocking 과정을 거친 다음 HRP substrate 발색시약으로 2 분 동안 반응시킨 후 western imaging system (CAS-400SM, Davinch-K Co., Ltd., Korea)기기를 이용하여 밴드를 확인하고 정량 및 결과를 산출하였다.To confirm iNOS and COX-2 protein expression, seed the cell line RAW 264.7 into 2 x 10 5 cells/well in a 6 well plate, and incubate for 24 hours in a 37%, 5% CO 2 incubator. Subsequently, after replacing the culture medium with serum-free DMEM medium, lipopolysaccharide (LPS) was treated to 1 ppm/well to induce an inflammatory reaction of cells, and each sample solution was treated by concentration, followed by 37°C, 5% CO 2 incubator Incubate for 24 hours. After that, the medium was removed, washed once with PBS, and then treated with 60 μL/well of RIPA buffer, each containing 0.1% of phosphatase and protease inhibitor, to lyse the cells and using a centrifuge at -4°C, 15 min at 15,000 rpm. During centrifugation, the obtained supernatant is transferred to a new tube. Thereafter, the amount of protein is quantified by a bradford assay, separated by mass by 10% SDS-PAGE using a power supply electrophoresis device, and transferred to a PVDF membrane. The membrane is blocked using a digital reciprocating shaker device for 5% skin milk 2 hours, primary antibody 2 hours, TBST solution 10 minutes (3 repetitions), secondary antibody 1 hour, TBST solution 10 minutes (3 repetitions). After rough reaction with HRP substrate coloring reagent for 2 minutes, the band was checked using a western imaging system (CAS-400SM, Davinch-K Co., Ltd., Korea) device, and quantitative and results were calculated.

4. Real-time PCR 분석을 통한 iNOS 및 COX-2 발현 억제 확인4. Real-time PCR analysis confirmed iNOS and COX-2 expression inhibition

1) cell lysis 및 cDNA 합성1) Cell lysis and cDNA synthesis

6 well plate에 cell seeding을 하고 24시간 동안 배양한 후 세포를 자극 시키고 시료 용액을 농도별로 처리한 뒤 37 ℃, 5% CO2 incubator에서 24시간 동안 배양시킨다. 상등액을 제거하고 Trizol lysis buffer 각 well에 1mL씩 분주하여 세포를 lysis 한 후 상온에 5분동안 방치한다. Trizol buffer 1mL 당 Chloroform 200 μL를 첨가여 30초동안 invert해준 5분 동안 방치한다. 원심분리기 -4℃에서 15,000rpm으로 15분 동안 원심분리 한 후 상등액을 500 μL를 e-tube로 옮긴다. 여기에 Iso-propanol 500 μL를 첨가해 천천히 invert해 준 후 5분 동안 방치한 후 다시 한번 원심분리기 -4℃에서 15,000rpm으로 15분 동안 원심분리시킨다. E-tube 바닥에 있는 RNA pellet을 확인한 후 상등액을 제거하고 75% ethanol로 RNA pellet을 세척한 후 남은 용매를 증발시켜 완전히 제거한다. RNA pellet을 diethylpyrocarbonate (DEPC) water 50 μL를 첨가하여 녹인 후 260 nm / 280 nm의 ratio를 확인하여 실험을 진행한다. After cell seeding on a 6 well plate and incubating for 24 hours, the cells are stimulated and the sample solution is treated by concentration, and then incubated for 24 hours in a 37°C, 5% CO 2 incubator. After removing the supernatant and dispensing 1 mL in each well of Trizol lysis buffer, the cells are lysis and left at room temperature for 5 minutes. 200 μL of Chloroform per 1 mL of Trizol buffer is added and left for 5 minutes after inverting for 30 seconds. Centrifuge After centrifugation at -4℃ for 15 minutes at 15,000 rpm, 500 μL of the supernatant is transferred to the e-tube. To this, 500 μL of Iso-propanol was added, inverted slowly, left for 5 minutes, and then centrifuged again at 15,000 rpm at -4° C. for 15 minutes. After checking the RNA pellet on the bottom of the E-tube, remove the supernatant, wash the RNA pellet with 75% ethanol, and evaporate the remaining solvent to completely remove it. After dissolving RNA pellet by adding 50 μL of diethylpyrocarbonate (DEPC) water, check the ratio of 260 nm / 280 nm and proceed with the experiment.

2) Real-time PCR2) Real-time PCR

SYBR Green PCR Mastet Mix(applied biosystem, UK)를 이용하여 cDNA와 TOPrealTM qPCR 2X PreMIX((Enzynomics, Daejeon, Korea), Primer를 넣고 ABI step one plus(Applied biosystem, California, USA) 기기를 이용하여 정량 분석을 하고 Stepone Software(Applied biosystem, California, USA)를 사용하여 95℃에서 2분간 denature시킨 후 95℃에서 10초, 60℃에서 15초, 72℃에서 20초간 반응하는 온도 순환 조건을 40회 반복한 결과를 분석하였다.SYBR Green PCR Mastet Mix (applied biosystem, UK) using cDNA and TOPreal TM qPCR 2X PreMIX ((Enzynomics, Daejeon, Korea), Primer, ABI step one plus (Applied biosystem, California, USA) After analyzing and denatured for 2 minutes at 95°C using Stepone Software (Applied biosystem, California, USA), the temperature cycling conditions of reacting at 95°C for 10 seconds, 60°C for 15 seconds, and 72°C for 20 seconds are repeated 40 times. One result was analyzed.

실험결과Experiment result

1. MTT assay에 의한 세포 독성 측정 결과1. Cytotoxicity measurement result by MTT assay

RAW 264.7 cell에 대한 세포 독성을 측정한 결과 대조군과 비교하여 대황 70%ethanol 추출물은 농도 500 μg/mL에서부터 20% 이상의 세포 독성을 나타내었다. MTT assay를 통한 세포 독성 측정 결과는 하기 도 6에 나타내었다.As a result of measuring the cytotoxicity of RAW 264.7 cells, 70% ethanol extract of rhubarb showed a cytotoxicity of more than 20% from a concentration of 500 μg/mL compared to the control group. The results of measuring cytotoxicity through MTT assay are shown in FIG. 6 below.

2. Nitric oxide 저해율 측정 결과2. Nitric oxide inhibition rate measurement result

농도별로 샘플을 처리하여 NO의 양을 측정한 결과 농도 의존적으로 감소하는 결과를 보였다. 최고농도인 1,000 μg/mL에서 54.9%의 저해효과를 보였다. Nitric oxide 저해율 측정 결과는 하기 도 7에 나타내었다.As a result of measuring the amount of NO by processing the sample for each concentration, it was found that the concentration was dependently decreased. It showed an inhibitory effect of 54.9% at the highest concentration of 1,000 μg/mL. Nitric oxide inhibition rate measurement results are shown in Figure 7 below.

3. Western blot을 통한 iNOS, COX-2 단백질 발현 측정 결과3. iNOS, COX-2 protein expression measurement result through Western blot

대황 70%ethanol 추출물의 iNOS 발현 억제율은 250 μg/mL에서 약 50.9%, COX-2에서는 약 17.3%의 효과를 나타내었다. Western blot을 통한 대황의 iNOS 생성저해 측정 결과는 도 8에 나타내었으며, Western blot을 통한 대황의 COX-2 생성저해 측정 결과는 도 9에 나타내었다. INOS 및 COX-2에 사용 된 프라이머의 서열은 표 10과 같다.The inhibition rate of iNOS expression of 70% ethanol extract of rhubarb was about 50.9% at 250 μg/mL and about 17.3% at COX-2. The measurement results of iNOS production inhibition of rhubarb through Western blot are shown in FIG. 8, and the measurement results of COX-2 production inhibition of rhubarb through Western blot are shown in FIG. 9. The sequences of the primers used for INOS and COX-2 are shown in Table 10.

GeneGene PrimerPrimer Sequence(5’→ 3’)Sequence(5’→ 3’) INOSINOS ForwardForward ACA TCG ACC CGT CCA CAG TATACA TCG ACC CGT CCA CAG TAT ReverseReverse CAG AGG GGT AGG CTT GTC TCCAG AGG GGT AGG CTT GTC TC COX-2COX-2 ForwardForward TCC CTA AAG GAA AAG TGG GACTCC CTA AAG GAA AAG TGG GAC ReverseReverse GAG CGC ATT AACCTC AGG ACCGAG CGC ATT AACCTC AGG ACC

4. Real-time PCR 분석을 통한 iNOS 및 COX-2 발현 억제 확인 결과4. Result of confirming iNOS and COX-2 expression inhibition through real-time PCR analysis

대황의 NO의 저해 기전을 보기 위해 iNOS의 발현율을 확인하고, PGE2의 저해 경로를 보기 위해 COX-2의 발현을 mRMA 수준에서 측정한 결과 위와 같이 나타내었다. 대황의 iNOS 발현 억제 효과는 최고 농도인 250 μL에서 약 74.3%를 나타내었고, COX-2 발현 억제 효과는 약 22.8%를 나타내었다. Real-time PCR 분석을 통한 iNOS 및 COX-2 발현 억제 확인 결과는 하기 도 10에 나타내었다.The expression rate of iNOS was confirmed to see the mechanism of inhibition of NO in rhubarb, and the expression of COX-2 was measured at mRMA level to view the inhibitory pathway of PGE 2 , and the results were shown above. The inhibitory effect of rhubarb on iNOS expression was about 74.3% at the highest concentration of 250 μL, and the inhibitory effect on COX-2 expression was about 22.8%. The results of confirming the inhibition of iNOS and COX-2 expression through real-time PCR analysis are shown in FIG. 10 below.

주름 개선 효과 측정 실험Wrinkle improvement effect measurement experiment

1. MTT assay에 의한 세포 독성 측정1. Measurement of cytotoxicity by MTT assay

HacaT cell을 96-well plate에 5×104 cells/well이 되게 0.18 mL 분주하고, 시료를 농도 별로 제조하여 0.02 mL 첨가 후 37℃, 5% CO2 incubator에서 24시간 배양하였다. 대황 70%ethanol 추출물은 5, 10, 25, 50, 100, 250, 500 μg/mL 농도별로 24시간 동안 처리 한 후 2.5mg/mL 농도로 제조한 MTT 용액을 0.02 mL 첨가하여 4시간 동안 배양시킨다. 그 후 배양액을 제거하고 각 well 당 DMSO(Dimethyl Sulfoxide, DUSAN) 0.1 mL를 가하여 실온에서 30분간 반응 시킨 뒤 ELISA reader로 540nm에서 흡광도를 측정하였다. 세포 독성 측정은 시료용액 첨가군과 무첨가군의 흡광도 감소율로 나타내었다.HacaT cells were dispensed into a 96-well plate at 0.18 mL so as to be 5×10 4 cells/well, samples were prepared for each concentration, and 0.02 mL was added, followed by incubation at 37° C. in a 5% CO 2 incubator for 24 hours. The 70% ethanol extract of rhubarb is treated for 24 hours for each concentration of 5, 10, 25, 50, 100, 250, 500 μg/mL, and then 0.02 mL of MTT solution prepared at a concentration of 2.5 mg/mL is added and incubated for 4 hours. . Thereafter, the culture solution was removed, and 0.1 mL of DMSO (Dimethyl Sulfoxide, DUSAN) per well was reacted for 30 minutes at room temperature, and absorbance at 540 nm was measured using an ELISA reader. Cytotoxicity was measured as a decrease in absorbance between the sample solution added group and the non-added group.

2. Western blot을 통한 MMP-1 단백질 발현 측정2. Measurement of MMP-1 protein expression through Western blot

MMP-1 단백질 발현을 확인하기 위하여 HaCat cell을 이용하여 6 well plate에 cell을 seeding 하고 37 ℃, 5% CO2 incubator에서 24시간 동안 배양시킨다. 그 뒤에 상등액을 최대한 제거하고 각 well 당 PBS를 2 mL씩 분주한 후 UV-B를 1분 동안 조사하여 자극시킨다. 배양액을 혈청 무첨가 DMEM 배지로 교환한 후 각 시료용액을 농도별로 처리한뒤 37 ℃, 5% CO2 incubator에서 24시간 동안 배양시킨다. 그 뒤에 배지를 제거하고 PBS로 1회 세척 후 phosphatase 와 protease inhibitor를 각각 0.1% 함유시킨 RIPA 버퍼를 60 μL/well로 처리하여 세포를 용해시키고 원심분리기를 이용하여 -4 ℃, 15,000 rpm에서 15분 동안 원심분리 시키고 얻은 상층액을 새 튜브에 옮긴다. 그 이후, bradford assay로 단백질의 양을 정량하고 power supply electrophoresis 기기를 이용하여 10% SDS-PAGE로 질량별 분리시키고 PVDF membrane에 옮긴다. membrane은 digital reciprocating shaker 기기를 이용하여 5% skin milk 2시간, primary antibody 2 시간, TBST solution 10분 (3회 반복), secondary antibody 1 시간, TBST solution 10 분 (3회 반복) 순의 blocking 과정을 거친 다음 HRP substrate 발색시약으로 2 분 동안 반응시킨 후 western imaging system (CAS-400SM, Davinch-K Co., Ltd., Korea)기기를 이용하여 밴드를 확인하고 정량 및 결과를 산출하였다.To confirm MMP-1 protein expression, seeding the cells in a 6 well plate using HaCat cells and incubating for 24 hours in a 37°C, 5% CO 2 incubator. After that, the supernatant is removed as much as possible, and 2 mL of PBS is dispensed for each well, and then irradiated with UV-B for 1 minute to stimulate. After replacing the culture solution with serum-free DMEM medium, each sample solution was treated by concentration, and then incubated for 24 hours in a 37°C, 5% CO 2 incubator. After that, the medium was removed, washed once with PBS, and treated with 60 μL/well of RIPA buffer containing 0.1% of phosphatase and protease inhibitor, respectively, to lyse the cells and using a centrifuge at -4°C and 15 minutes at 15,000 rpm. During centrifugation, the obtained supernatant is transferred to a new tube. Thereafter, the amount of protein is quantified by a bradford assay, separated by mass by 10% SDS-PAGE using a power supply electrophoresis device, and transferred to a PVDF membrane. The membrane is blocked using 5% skin milk 2 hours, primary antibody 2 hours, TBST solution 10 minutes (3 repetitions), secondary antibody 1 hour, and TBST solution 10 minutes (3 repetitions) using a digital reciprocating shaker device. After rough reaction with HRP substrate coloring reagent for 2 minutes, the band was checked using a western imaging system (CAS-400SM, Davinch-K Co., Ltd., Korea) device, and quantitative and results were calculated.

실험결과Experiment result

1. MTT assay에 의한 세포 독성 측정 결과1. Cytotoxicity measurement result by MTT assay

HaCaT cell에 대한 대황 70%ethanol 추출물의 세포 독성을 측정한 결과 대조군과 비교하여은 농도 50 μg/mL에서부터 20% 이상의 세포 독성을 나타내었다. MTT assay에 의한 세포 독성 측정 결과는 하기 도 11에 나타내었다.As a result of measuring the cytotoxicity of 70% ethanol extract of rhubarb against HaCaT cells, compared to the control group, it showed cytotoxicity of 20% or more from a concentration of 50 μg/mL. Cytotoxicity measurement results by MTT assay are shown in Figure 11 below.

2. Western blot을 통한 MMP-1 단백질 발현 측정 결과2. Measurement result of MMP-1 protein expression through Western blot

MMPs는 피부의 섬유아세포, 각질형성세포를 비롯하여 많은 세포들로부터 분비된다. HaCaT cell(각질형성세포)에 대한 대황 70%ethanol 추출물의 발현 억제효과를 확인한 결과 25 μg/mL에서 약 50%의 발현 억제율을 나타내었다. Western blot을 통한 MMP-1 단백질 발현 측정 결과는 하기 도 12에 나타내었다.MMPs are secreted from many cells, including fibroblasts and keratinocytes in the skin. As a result of confirming the expression inhibitory effect of 70% ethanol extract of rhubarb on HaCaT cells (keratinocytes), the expression inhibition rate was about 50% at 25 μg/mL. Measurement results of MMP-1 protein expression through Western blot are shown in FIG. 12 below.

결론적으로 상기 실시예 1 내지 8을 실시한 결과를 통해, 본 발명의 일 실시형태에 따른 화장료 조성물은 에탄올이나 물을 이용해 제조된 대황 추출물의 유효성분을 함유함으로써, 항산화 활성, 항염증, 세포 독성 및 주름 개선 효과가 있는 것을 확인하였다.In conclusion, through the results of Examples 1 to 8, the cosmetic composition according to an embodiment of the present invention contains an active ingredient of a rhubarb extract prepared using ethanol or water, thereby providing antioxidant activity, anti-inflammatory, cytotoxic, and It was confirmed that there was a wrinkle improvement effect.

이상, 실시예를 들어 본 발명을 상세하게 설명하였으나, 본 발명은 상기 실시예에 한정되지 않으며, 여러 가지 다양한 형태로 변형될 수 있고, 본 발명의 기술적 사상 내에서 당 분야에서 통상의 지식을 가진 자에 의하여 여러 가지 많은 변형이 가능함이 명백하다. 또한, 청구범위의 기재된 본 발명의 기술적 사상을 벗어나지 않는 범위 내에서 당 기술분야의 통상의 지식을 가진 자에 의해 다양한 형태의 치환, 변형 및 변경이 가능할 것이며, 이 또한 본 발명의 범위에 속한다고 할 것이다.As described above, the present invention has been described in detail with reference to examples, but the present invention is not limited to the above embodiments, and may be modified in various ways, and having ordinary knowledge in the art within the technical spirit of the present invention. It is clear that many variations are possible by the ruler. In addition, various forms of substitutions, modifications and changes will be possible by those skilled in the art without departing from the technical spirit of the present invention described in the claims, and this also belongs to the scope of the present invention. something to do.

Claims (4)

대황 추출물을 유효성분으로 포함하는 것을 특징으로 하는 화장료 조성물.Cosmetic composition comprising a rhubarb extract as an active ingredient. 청구항 1에 있어서,
상기 대황 추출물은,
건조하여 분쇄한 대황 100중량부에 대해 800 내지 1200중량부의 에탄올을 첨가한 후, 실온에서 20 내지 25시간 동안 추출하여 대황 추출액을 제조하는 추출단계;
상기 추출단계에서 제조된 대황 추출액에 함유된 고형분을 분리 제거하고, 고형분이 제거된 추출액을 40 내지 50℃의 온도에서 감압농축하여 10 내지 20Brix의 대황 농축액을 제조하는 농축단계; 및
상기 농축단계에서 제조된 대황 농축액을 -70 내지 -80℃의 온도에서 동결건조하여 대황 추출물을 제조하는 동결건조단계;를 포함하여 제조되는 것을 특징으로 하는 화장료 조성물.
The method according to claim 1,
The rhubarb extract,
An extraction step of adding 800 to 1200 parts by weight of ethanol to 100 parts by weight of dried and crushed rhubarb, followed by extraction for 20 to 25 hours at room temperature to prepare a rhubarb extract;
Concentration step of separating and removing the solid content contained in the rhubarb extract prepared in the extraction step, and concentrated under reduced pressure at a temperature of 40 to 50 ℃ the solid content is removed to prepare a rhubarb concentrate of 10 to 20 Brix; And
A cosmetic composition comprising a; lyophilization step of preparing a rhubarb extract by freeze-drying the rhubarb concentrate prepared in the concentration step at a temperature of -70 to -80°C.
청구항 1에 있어서,
상기 대황 추출물은,
건조하여 분쇄한 대황 100중량부에 대해 800 내지 1200중량부의 물을 가한 후, 90 내지 100℃에서 2 내지 3시간 동안 열수 추출하여 대황 추출액을 제조하는 추출단계;
상기 추출단계에서 제조된 대황 추출액에 함유된 고형분을 분리 제거하고, 고형분이 제거된 추출액을 60 내지 70℃의 온도에서 감압농축하여 10 내지 20Brix의 대황 농축액을 제조하는 농축단계; 및
상기 농축단계에서 제조된 대황 농축액을 -70 내지 -80℃의 온도에서 동결시킨 후 이를 동결건조하여 대황추 출물을 제조하는 동결건조단계;를 포함하여 제조되는 것을 특징으로 하는 화장료 조성물.
The method according to claim 1,
The rhubarb extract,
An extraction step of adding 800 to 1200 parts by weight of water to 100 parts by weight of dried and crushed rhubarb, followed by hot water extraction at 90 to 100°C for 2 to 3 hours to prepare a rhubarb extract;
Concentration step of separating and removing the solid content contained in the rhubarb extract prepared in the extraction step, and concentrated under reduced pressure at a temperature of 60 to 70 ℃ the solid content is removed to prepare a 10 to 20 Brix rhubarb concentrate; And
A cosmetic composition comprising a; a freeze-drying step of preparing a rhubarb extract by freezing the rhubarb concentrate prepared in the concentration step at a temperature of -70 to -80°C and then freeze-drying it.
청구항 1에 있어서,
상기 화장료 조성물은 화장수, 로션, 세럼, 마사지크림, 영양크림, 모이스처크림, 핸드크림, 에센스, 영양에센스, 바디로션으로 구성된 군으로부터 선택된 어느 하나의 제형으로 제조되는 것을 특징으로 하는 화장료 조성물.
The method according to claim 1,
The cosmetic composition is a cosmetic composition characterized in that it is prepared in any one formulation selected from the group consisting of lotion, lotion, serum, massage cream, nutrition cream, moisture cream, hand cream, essence, nutrition essence, body lotion.
KR1020180170136A 2018-12-27 2018-12-27 Composition for cosmetic comprising compounds extracted from eisenia bicyclis KR20200081542A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020180170136A KR20200081542A (en) 2018-12-27 2018-12-27 Composition for cosmetic comprising compounds extracted from eisenia bicyclis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020180170136A KR20200081542A (en) 2018-12-27 2018-12-27 Composition for cosmetic comprising compounds extracted from eisenia bicyclis

Publications (1)

Publication Number Publication Date
KR20200081542A true KR20200081542A (en) 2020-07-08

Family

ID=71599891

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020180170136A KR20200081542A (en) 2018-12-27 2018-12-27 Composition for cosmetic comprising compounds extracted from eisenia bicyclis

Country Status (1)

Country Link
KR (1) KR20200081542A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220075077A (en) * 2020-11-27 2022-06-07 재단법인 환동해산업연구원 A cosmetic composition containing eisenia bicyclis extract for skin whitening and wrinkle treatment, and manufacturing method thereof
KR20220152594A (en) 2021-05-07 2022-11-17 세명대학교 산학협력단 Herbal composition having anti-inflammatory effect comprising the extract of eisenia bicyclis as an active ingredient

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100966128B1 (en) 2008-01-10 2010-06-25 대구가톨릭대학교산학협력단 Enzymatic extracts, its formulated pill from Eisenia bicyclis for lowering blood lipid and glucose, and a preparation method thereof
KR20110057586A (en) 2009-11-24 2011-06-01 학교법인 선목학원 A composition for preventing or treating diabetes based on eisenia bicyclis
KR20130141874A (en) 2012-06-18 2013-12-27 부경대학교 산학협력단 Antibiotics composition containing phlorotannins from eisenia bicyclis

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100966128B1 (en) 2008-01-10 2010-06-25 대구가톨릭대학교산학협력단 Enzymatic extracts, its formulated pill from Eisenia bicyclis for lowering blood lipid and glucose, and a preparation method thereof
KR20110057586A (en) 2009-11-24 2011-06-01 학교법인 선목학원 A composition for preventing or treating diabetes based on eisenia bicyclis
KR20130141874A (en) 2012-06-18 2013-12-27 부경대학교 산학협력단 Antibiotics composition containing phlorotannins from eisenia bicyclis

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220075077A (en) * 2020-11-27 2022-06-07 재단법인 환동해산업연구원 A cosmetic composition containing eisenia bicyclis extract for skin whitening and wrinkle treatment, and manufacturing method thereof
KR20220152594A (en) 2021-05-07 2022-11-17 세명대학교 산학협력단 Herbal composition having anti-inflammatory effect comprising the extract of eisenia bicyclis as an active ingredient

Similar Documents

Publication Publication Date Title
KR102100270B1 (en) Composition for skin cell regeneration, anti-wrinkle, anti-inflammation, or skin whitening
KR101853687B1 (en) Antiinflammatory compositions containing Steron Fraction of Pyropia yezoensis extracts and preparing method of the same
KR101595166B1 (en) Composition containing scirpusin B, and process for producing composition containing scirpusin B
KR20200081542A (en) Composition for cosmetic comprising compounds extracted from eisenia bicyclis
KR20190036330A (en) Anti-oxidant Composition Comprising Heated Radish Extract
KR102150122B1 (en) Antioxidant composition comprising extract of Apis mellifera male pupa
KR101168169B1 (en) Rubus coreanus Miquel oil composition, use and preparation method thereof
Pagano et al. Starch-based sustainable hydrogel loaded with Crocus sativus petals extract: A new product for wound care
Cheng et al. Pine pollen: A review of its chemical composition, health effects, processing, and food applications
Hwang et al. Effect of heat treatment on the antioxidant properties of yacon (Smallanthus sonchifolius)
KR102153355B1 (en) A composition comprising Caulerpa racemosa extracts or fraction having anti-oxidation or anti-inflammation activity
Chunhieng et al. Detailed study of the juice composition of noni (Morinda citrifolia) fruits from Cambodia
KR102099573B1 (en) Manufacturing method of fermented product of fucoidan for functional cosmetics having good whitening function and anti-wrinkling function
KR101807080B1 (en) Antioxidant or antiinflammatory composition comprising clamworm
Aydin et al. Antioxidant, anti-urease and anti-elastase activities of Usnea longissima Ach.
KR20170052556A (en) Cosmetic compositions for improving skin aging or skin moisturizing comprising fucosterol
CN113730291A (en) Torreya grandis compound oil, preparation method and application
KR20190136769A (en) Composition for antioxidant and anti-inflammatory comprising fraction of Ledum palustre L. extract as effective component
KR101957772B1 (en) Ishige okamurae extract composition for skin whitening and anti-wrinkling and manufacturing thereof
KR102123565B1 (en) A composition comprising seaweed extracts or fraction having anti-oxidation or anti-inflammation activity
Raj et al. Nutritional and Human Healthcare Aspects of Ulva Lactuca
KR102393749B1 (en) FUNCTIONAL COSMETIC COMPOSITION COMPRISING Schisandra chinensis OIL AS EFFFECTIVE INGREDIENT
KR20190029198A (en) Manufacturing method of fermented product of fucoidan for functional cosmetics having good whitening function and anti-wrinkling function
Kim et al. Anti-inflammatory and antioxidant activities of Sargassum horneri extract in RAW264. 7 macrophages
KR101661423B1 (en) anti-oxidant and anti-inflammation composition extracted from Isodon excisus, and its extracting method

Legal Events

Date Code Title Description
E601 Decision to refuse application